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The first step towards the treatment of any disease is diagnosis; 
however, a major hindrance towards monitoring diseases remains the 
availability of rapid diagnostic tests to detect DNA and RNA biomarkers. 
Unfortunately, traditional assays to test for these analytes are limited to 
centralized laboratories. For example, the gold-standard sample preparation 
methods to isolate and purify nucleic acid analytes require multiple hands-on 
steps, numerous chemicals, and specialized equipment. Recent research 
endeavors have made incremental progress to simplify these procedures by 
miniaturizing these steps, but still require the numerous chemicals and bulky 
peripheral instrumentation for operation. Similarly, gold-standard detection 
methods, namely quantitative PCR (qPCR), rapidly cycle between near-boiling 
  
temperatures, thus mandating the use of sophisticated instrumentation with 
high power demands. These methods for sample preparation and target 
detection are overall laborious, time-consuming, and require technical 
expertise thereby imposing large time, and financial costs for diagnoses. To 
address these challenges, this dissertation aims to shift the paradigm of how 
we approach sample preparation for nucleic acid isolation, and to design novel 
assays for rapid, specific, and multiplexed detection in a single reaction.  
First, a new sample preparation method is presented that 
simultaneously accomplishes three time-consuming sample preparation steps 
(cell lysis, DNA capture, and purification) in less than ten minutes. This platform 
enables DNA isolation from whole blood droplets, with subsequent 
amplification and detection of both genomic and pathogenic DNA bound to the 
microparticle surface. Second, we explore optimizations of a popular 
isothermal DNA amplification technique that previously demonstrated multiplex 
detection of bacterial genomes. By developing a triplex assay towards the 
identification of drug resistant bacteria, we address inhibition that is normally 
observed with this technique, and present strategies towards achieving 
amplification within 30 minutes. Lastly, we outline design consideration towards 
the development of a novel amplification scheme specifically for microRNA 
targets. This system leverages both DNA and RNA polymerases to achieve 
positive feedback and thus, requires evaluation of enzymes, sequence design, 
and buffers to inform assay design. Together, this work advances the 
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Chapter 1. Introduction 
 
 Currently, gold standard approaches to nucleic acid amplification tests 
(NAATs) are limited to central laboratory facilities due to the necessary 
instrumentation, the infrastructure required to support the instrumentation, and 
the need for trained technicians to perform these assays. However, this model 
imposes large financial and time burdens, and creates a significant window 
between sample collection and diagnostic result (sample-to-answer time). In 
environments such as rural clinics or emergency care, where a rapid result is 
required to inform immediate treatment, the central laboratory model hinders 
informed clinical decisions and thus patient care. As a result, a large focus 
within the diagnostic community is the development of near-patient or point-of-
care (POC) testing with the goals of testing immediately upon sample collection 
and achieving rapid assay and analysis results for quicker sample-to-answer 
times. Advancements in this area would allow clinicians to not only perform 
these tests quickly and cheaply, but also facilitate a more dynamic and 
informed approach towards targeted treatment for patients. 
 Rapid diagnostic tests (RDTs) such as glucose meters and pregnancy 
tests have already been employed within the healthcare system. Given their 
success and prevalence in the healthcare system, the development of RDTs 
has been expanded for the detection of infectious diseases, such as human 





assays for infectious disease detection, most typically leverage a variation of a 
binding assay specifically for protein, commonly agglutination assays, 
enzyme-linked immunosorbent assays, or lateral flow immunochromatographic 
tests.2 However, these methods of detection are often inferior in both sensitivity 
and specificity compared to the molecular diagnostics that would normally be 
performed in the central lab setting.3 These deficiencies motivate further 
development of diagnostic assays, for both protein and nucleic acids that are 
on par with their molecular diagnostic counterparts with regard to performance, 
while addressing the challenges of cost and time. 
 Several commercial POC NAATs have already been developed, where 
the model comprises a reader that contains the necessary hardware and 
detection instrumentation, and separate cartridge consumables that are 
specific to the target of interest. The most popular of these platforms has been 
the Cepheid XPert®. This fully integrated system centers on a cartridge that 
enables testing of nucleic acid targets directly from a complex matrix such as 
blood. The cartridge couples with the reader to perform cell lysis and DNA 
isolation, and DNA amplification.4,5 While these systems and other commercial 
platforms have successfully integrated sample preparation, amplification, and 
detection into one automated platform with a sample-to-answer readout, their 
impact at the POC has yet to be realized due to their cost, energy consumption, 
the need for a power source and a specialist for maintenance and repair.  
 To remedy the aforementioned challenges associated with NAATs, 





amplification methods, devising more specific detection methods, and 
redesigning sample preparation methods. The first focus aims to devise 
alternative methods and technologies to replace the temperature cycling-driven 
method of amplification, with a variety of amplification schemes that operate at 
a single temperature. These techniques, known as isothermal amplification 
schemes, lead to less sophisticated and bulky instrumentation, which 
translates to a more affordable system for POC applications. Detection from 
isothermal methods can be quantified by using the same intercalating dyes that 
are traditionally used, and thus can be easily integrated with developed 
fluorescence detectors amenable to POC environments. To further drive down 
costs, lateral flow approaches have been employed in which immobilized 
oligonucleotides hybridize to the amplicons produced during the amplification 
reaction and are detected with nanoparticles.6–8 However, this increases the 
sample-to-answer time with the requirement of a post-amplification detection 
method. Overall, isothermal methods offer promise towards the development 
of a POC NAAT, but often suffer from nonspecific amplification due to the 
constant enzyme activity at these single operating temperatures. 
 The second challenge involves addressing the need for specific target 
detection, particularly with isothermal amplification schemes. As mentioned 
previously, fluorescence is often achieved with an intercalating dye, a 
nonspecific DNA binding dye. Therefore, distinguishing the results of on-target 
versus off-target amplification is impossible without post-amplification 





resonance energy transfer (FRET) have been designed to hybridize directly to 
the target of interest. The main challenge with employing this type of readout 
with isothermal amplifications is that not all of these techniques enable FRET 
probe degradation for signal generation. As a result, many groups have used 
a molecular beacon approach. Similar to the FRET probes, molecular beacons 
also leverage two labels; however, here, binding of a reaction product to the 
molecular beacon drives signal generation. These molecular beacons are 
complex in their design, primarily to ensure that nonspecific hybridization does 
not occur. For applications where multiple nucleic acid targets are assayed in 
a single tube, minimizing nonspecific interactions becomes increasingly 
difficult. 
 Lastly, despite the advances made towards simplifying amplification 
methods, sample preparation remains a major hindrance in realizing a truly 
integrated and low-cost system for NAATs. This is primarily because most 
efforts focus on miniaturizing the gold standard methods of sample preparation, 
namely cell lysis and DNA isolation, and DNA purification. Cell lysis has been 
integrated into devices with the incorporation of microparticles, thermal 
heaters, and chemical agents. However, the arduous process of DNA 
purification remains a bottleneck in this process. Purification methods often 
require multiple precise buffer exchanges, and as a result, a complex fluid 
handling system needs to be incorporated within the system in order to perform 





solutions that move away from this model of sample preparation are critical to 
realizing a POC NAAT, but have yet to be developed. 
 Towards the goal of streamlining methods required for NAATs, this work 
develops novel technologies to shift the paradigm of how we approach sample 
preparation, and to present strategies for the design of multiplex isothermal 
amplification schemes for a variety of nucleic acid targets. Specifically, Chapter 
3 details the development of a microparticle-based platform that enables cell 
lysis and DNA extraction in less than 10 minutes. This platform enables 
amplification directly off of the solid phase, and is amenable to future 
automation of the platform. Chapter 4 assesses a FRET-based approach for 
loop-mediated isothermal amplification, a popular isothermal amplification 
method, and presents strategies to better inform assay design for multiplex 
detection towards the detection of methicillin-resistant Staphylocuccus aureus 
(MRSA). Lastly, Chapter 5 presents a novel amplification technique for the 
direct detection of microRNA, a growing target of interest in biomarker 
discovery. Here, I outline the steps one should consider when designing a 










Chapter 2. Molecular diagnostics for nucleic acid biomarkers 
 
 Currently, most molecular diagnostics are performed exclusively in 
centralized laboratories due to the need for sophisticated instrumentation, and 
the technical expertise required to handle these assays. With medical care now 
shifting to provide a patient-centric approach, there is an increased need for 
sensitive and specific tests that can be performed in near-patient settings (i.e. 
doctors’ offices, rural clinics, at-home testing, etc.), also termed point-of-care 
(POC) testing. The two major challenges towards an integrated device for 
nucleic acid amplification tests are sample preparation, and amplification that 
allows for specific, multiplexed detection. This chapter will detail the strategies 
and recent advancements to devise novel solutions and approaches for both 
these modules. 
2.1 Nucleic acid amplification tests 
NAATs are a powerful tool used every day for diagnosing and monitoring 
various diseases. These tests take advantage of the gene-specific sequences 
of DNA that can be directly detected, and achieve greater sensitivity than other 
protein detection methods9 (i.e. immunoassays). As a result, NAATs are a 
commonly-used diagnostic for antimicrobial resistance,10 infections caused by 
immunovariant viruses and early detection of viral infections.11 Due to the 
required training and the sophisticated instrumentation, NAATs are most 





low resource-settings where the technical support for these facilities is lacking 
or absent. 
NAATs are comprised of three main modules: sample preparation, 
amplification, and detection.12 Sample preparation often involves a 
multi-reagent procedure that involves three major steps. First, DNA-containing 
cells within a complex matrix, such as blood, are lysed using chaotropic salts 
to disrupt hydrogen bonding and effectively denature proteins. The DNA is then 
extracted from the lysate, either by separation using solvents or spin columns. 
Lastly, the DNA is purified for downstream analysis. The most common 
amplification method is polymerase chain reaction (PCR) and requires 
thermocycling to facilitate DNA melting, primer annealing and extension to 
produce PCR products, or amplicons, at an exponentially increasing rate. 
Finally, real-time detection is most commonly realized using fluorescence with 
the use of nucleic acid stains or oligonucleotide probes that are cleaved during 
extension. Overall, sample preparation and amplification are the two modules 
that are the foci of current diagnostics research, as they remain to be the most 
time- and resource-consuming aspects.  
2.2 Sample preparation 
For most NAATs, a sample taken directly from the patient must be 
processed to yield a pure DNA sample prior to analysis as proteins and cellular 
debris present can inhibit the assay. Standard clean-up protocols require either 
chemical lysis with a solid-phase support to purify and immobilize the released 





the chemicals used to lyse cells and the solvents used to purify DNA can inhibit 
downstream amplification, and multiple buffer exchanges are required to bind, 
wash, and elute the DNA. These protocols are unrealistic for POC applications 
given that they are difficult to integrate with lab-on-a-chip (LOC) platforms 
without external equipment and technical expertise. This section details the 
gold-standard methods, outlines why they are unsuitable for POC applications, 
and reviews current research endeavors aiming to address the challenges 
associated with implementation of sample preparation in an integrated device. 
2.2.1 Conventional methods for sample preparation 
In order to perform any molecular diagnostic in a central laboratory 
setting, a patient sample must be purified to isolate the given target. There are 
many different methods for nucleic acid purification of a cell lysate, such as 
phenol-chloroform extraction and ethanol precipitation,13,14 however these 
methods rely on sophisticated instrumentation (i.e. centrifuges), and various 
buffers, consisting of high and low ionic conditions or toxic chemicals, as well 
as technical expertise to conduct these procedures.  
These methods have been simplified by using a solid phase extraction15 
in a spin-column by reducing DNA extraction and purification to 30 minutes 
(Figure 2.1); however this method presents the same disadvantages as the 
aforementioned methods. Given the multiple steps and the need for 
centrifugation involved in all preparation methods, there is a high level of 





high-throughput method for purifying and extracting multiple samples, due to 
the cumbersome hands-on steps required. 
In an effort to make NAATs more accessible to POC, research has been 
focused on miniaturizing these methods using microfluidic platforms. At the 
micron scale, the advantages of these systems involve smaller sample 
volumes, and faster assay times.16–18 However, many of these systems perform 
sample preparation off chip. While cell lysis can be integrated into a microfluidic 
format easily, either by microfabrication to achieve mechanical lysis for 
bacteria,19–22 integration of heaters for thermal lysis,23–26 or addition of 
chemicals for chemical lysis,27–29 integration of DNA extraction from a lysate is 
not as straightforward. The most obvious solution is to integrate the macroscale 
Figure 2.1. Schematic detailing solid-phase extraction. A cell suspension is first lysed with 
chaotropic salts prior to DNA extraction. The lysate is then added to a spin column with a 
silica membrane so that the DNA will bind to the solid phase upon centrifugation. The 
chaotropic salts present in the lysate facilitate this by forming salt bridges between the silica 
membrane and the DNA backbone (both are negatively charged). Washes with ethanol are 
added to remove protein aggregates and debris, and finally, a low-ionic strength buffer or 





solid phase extraction techniques within a microfluidic device, however the 
challenges with this method involve fabricating the valves necessary to pass 
the different buffer across the silica membrane. Additionally, this method still 
requires multiple reagent exchanges, so these systems require fluid handling 
control that adds to the complexity of the overall system. The ideal system 
would allow a one-step method of extracting DNA from a cell lysate. 
2.2.2 Microparticle- and polymer-based methods 
2.2.2.1 Microparticle-based sample preparation 
Historically, bead-based approaches have offered a one-sided solution 
towards achieving a stream-lined cell lysis and DNA extraction method. For 
example, glass beads have historically been used to mechanically rupture 
cells,30 however it still requires the later steps of DNA purification for 
downstream analyses. Similarly, surface-modified magnetic particles14 have 
been shown to effectively isolate DNA but only from a lysed cell suspension as 
beads begin to disintegrate under cell lysis conditions. However, magnetic 
microparticle platforms have pushed the diagnostics field towards a simplified 
approach to sample preparation as they minimize the instrumentation demands 
as well as the consumables required when compared to gold-standard DNA 
extraction methods. Because magnetic particles enable easy separation when 
the DNA is complexed onto the bead surface, the most resource intensive 
aspect involves the multiple buffer exchanges. Briefly, microparticles are 





affinity-based DNA binding. Particles functionalized with silica have the same 
reagent-exchange requirements31–33 to its macroscale counterpart, but no 
longer require centrifugation or additional consumables. For amine-coated 
magnetic microparticles, DNA is bound onto the surface of these microparticles 
by taking advantage of the electrostatic charges present on both the particles 
and the DNA. However, instead of using buffers of different ionic conditions, 
buffers of different pH are employed instead,34 thereby removing the concerns 
of salts and alcohol that inhibit PCR downstream. At low pH, the amines 
present of the microparticle surface become protonated and electrostatically 
bind to the negatively-charged DNA. With a high pH buffer, these amines 
become neutrally charged, resulting in the elution of DNA from the microparticle 
surface. The elution step done at room temperature results in roughly 40% of 
the DNA being released, most likely due only a fraction of the amines becoming 
neutral; to ensure complete elution of the bound DNA, the elution step is done 
at 80 °C to melt the DNA off the bead surface, resulting in 100% release. As a 
result, the use of aminated beads also have the same reagent-exchanges 
characteristic of gold-standard methods, and thus both aminated and silica 
coated particles provide an incremental improvement towards a one-step cell 
lysis and DNA extraction platform. 
To address the need for simplified sample preparation, commercial 
products that leverage magnetic particles have targeted the need for 
streamlined DNA capture and purification. One such product are DYNABeads 





pipetting motion efficiently lyses a cell suspension and allows for the released 
DNA to complex the DYNABeads. After a series of washes, either the DNA can 
be eluted off the DYNABead surface, or the DNA/DYNABead complexes can 
be added directly into a PCR reaction without significant inhibition.35 However, 
this protocol does require separate buffers for binding and washing steps, 
therefore reagent-exchange is still necessary for this platform.  
2.2.2.2 Membrane-based sample preparation 
While microparticle-based approaches present a facile method for cell 
lysis and DNA extraction, they do not address the issues of sample collection 
or sample transfer. Microparticle-based methods still rely on a skilled technician 
to pipet the sample and the microparticles for sample preparation and then 
transfer the suspension for amplification and analysis. As a result, membranes 
have become an increasingly popular avenue36,37 in developing a low-cost lysis 
and DNA extraction technology. Overall, membrane substrates offer the 
advantages of wicking to transport fluids, having a porous or fibrous network to 
allow for filtration and storage, and allowing for flexible modification methods 
(either during fabrication, or after with the use of chemicals) that further 
enhance the substrate’s storage abilities. For sample collection and transfer, 
having a membrane-based system greatly simplifies the amount of user 
handling as a sample could be directly spotted onto the substrate. Depending 
on the overall scheme, the flexibility of paper could facilitate sample transfer 






The two most popular and well-known paper-based platforms are 
developed by Whatman: the 903 protein saver platform and the FTA platform. 
Whatman advertises these two platforms specifically for sample collection, 
transport and storage. The 903 protein saver platform was first developed for 
dried blood spot collection for screening purposes. However, this platform does 
not offer an integrated method for cell lysis or DNA extraction, leaving the user 
to perform standard purification procedures38 mentioned previously. The FTA 
platform is advertised as a substrate that lyses cells, denatures proteins and 
protects nucleic acids from nucleases and UV damage. However, the key 
limitation in using the FTA platform is that proprietary reagents must be used 
in order to either remove protein aggregates or to elute the DNA from the 
substrate for downstream analysis.38 While the Whatman platforms do achieve 
membrane-based cell lysis specifically for sample collection, this is an 
incremental step and does not address the key issues of the high number of 
hands-on steps and sample transfer. 
Given the aforementioned benefits of using a paper substrate for a 
diagnostic, research groups have developed numerous lateral flow assays for 
DNA detection. As a module within the assay, groups have incorporated a DNA 
capture or DNA concentration step, either with the use of glycogen working in 
conjunction with chaotropic salts,39,40 or using chitosan.41 However, because 
these platforms require the transport of DNA across the substrate via wicking, 
only small DNA targets can be tested using this format. If bacterial genomes or 





wick along the length of the substrate; if genomic DNA was assayed on this 
platform, the DNA would have to be sheared prior to running the assay, adding 
hands-on steps and user handling. 
2.2.2.3 Chitosan-based sample preparation methods  
Chitosan is a biopolymer that has historically been leveraged for gene 
delivery given that it is a naturally derived polymer, allowing for a biocompatible, 
non-immunogenic and biodegradable vehicle.42 Molecular weight has been 
thoroughly investigated to determine optimal conditions for polyplex formation 
between the chitosan and the DNA material used for transfection.43 Molecular 
weight has been shown to impact not only the particle size of the polyplexes, 
but also the binding affinity between the chitosan and the nucleic acid, and DNA 
dissociation from the polyplex. Specifically, chitosan of molecular weight 
150 kDa and higher has exhibited higher DNA binding with limited release of 
the DNA cargo whereas chitosan of lower molecular weight has been shown to 
be less stable in forming polyplexes,44 resulting in poor DNA binding and high 
release of DNA from the polyplex when formed. 
Leveraging knowledge from these gene delivery studies, chitosan has 
since been employed for DNA extraction, as the amines present along the 
polysaccharide can also be employed for charge-based binding. Chitosan 
consists of two main subunits: ß-D-glucosamine and ß-N-acetyl-D-
glucosamine. The presence of the deacetylated glucosamine unit contributes a 





protonated at pH lower than its pKa. At pH lower that chitosan’s pKa, the 
protonated amine groups allow for strong electrostatic interactions between the 
chitosan and DNA backbone. When the pH is greater than chitosan’s pKa, 
these amine groups become neutrally-charged and the diminished electrostatic 
interactions allow for the bound DNA to then elute off of the chitosan. Cao, et 
al.,46 demonstrated charge-switching for DNA extraction using chitosan-coated 
silica particles, where 90% of λ-phage DNA in pH 5 buffer was captured onto 
the surface of chitosan-coated particles. When chitosan-coated particles were 
incubated with a pH 9 buffer, roughly 87.5% was extracted, thereby exhibiting 
the first chitosan platform for DNA extraction for low volume samples.  
Since this initial demonstration, chitosan has been leveraged in 
microfluidic biosensors to improve upon DNA-based assays. Byrnes, et al., 
demonstrated this charge-switching behavior for the purification and 
concentration of DNA by loading chitosan into nitrocellulose and glass fiber 
membranes towards the development of lateral flow test.41 The inclusion of 
chitosan into the lateral flow strips allowed for purification and concentration 
from matrices with interfering agents such as excess protein and non-target 
DNA. For large sample volumes, this platform is extremely flexible for its 
applications for urine testing or environmental water testing, without 
compromising DNA recovery. Similarly, Kendall, et al., leveraged chitosan by 
functionalizing it onto a porous monolith within a thermoplastic, microfluidic chip 





provide systems that provide high yield, but are limited to applications where 
target DNA is already in solution.  
2.2.2.4 Outlook for NAAT sample preparation 
Gold-standard sample preparation methods have remained tethered to 
the central laboratory due to the need for sophisticated instrumentation, and 
multiple hands-on steps that require technical expertise. However, by 
leveraging different form factors such as microparticles and paper, and 
employing materials commonly employed for DNA binding, DNA extraction 
methods have improved by removing the requirement for centrifugation. These 
methods still require multiple buffer exchanges that can be cumbersome to 
implement within a microfluidic device or integrated system. The ideal sample 
preparation platform would facilitate simultaneous cell lysis and DNA extraction 
with a single-buffer system, all occurring within a single tube. In doing so, this 
would eliminate the many hands-on steps that typically require user 
intervention, as well as the complicated fabrication required for multiple buffer 
exchanges. Shifting the sample preparation paradigm to a single-tube format 
would enable a platform that can be easily automated, and facilitate 
downstream amplification with minimal inhibitory effects. The subsequent 
section will discuss work that has been done in our lab to address the 
challenges discussed above, and Chapter 3 will outline the improvements to 
our platform to enable simultaneous cell lysis and DNA extraction towards 





2.2.2.5 Chitosan microparticles for DNA isolation and amplification 
Previously, our group has leveraged whole magnetic microparticles 
made of chitosan to characterize DNA capture and amplification directly from 
the microparticle surface.48 Whole chitosan microparticles were fabricated by 
crosslinking the outer layer of chitosan emulsions (Figure 2.2A, B).  Due to the 
dense matrix of chitosan, we observed an alkaline shift in pKa, resulting in 
strong electrostatic between the chitosan and DNA that prevented the DNA 
from eluting off the surface (Figure 2.2C). This is similar to what groups in the 
drug delivery field have previously observed, and enables direct amplification 
of the bound genomes from the microparticle surface, eliminating the need for 
elution and its required hands-on steps. By leveraging this shift in pKa, we have 
devised a simplified approach to sample preparation by using chitosan whole 
Figure 2.2. Characterization of whole chitosan microparticles. (A) Schematic of an individual 
microparticle where outer layer of chitosan in crosslinked and inner layers remain 
uncrosslinked. (B) SEM image of chitosan microparticle clusters. Individual particles are 
roughly 0.5 to 8 µm in diameter, and aggregate into clusters that are roughly 20 µm in 
diameter. Scale bar is 10 µm. (C) Capture efficiency of chitosan microparticles using plasmid 
DNA (pUC19) at pH lower and higher than the pKa of chitosan (6.5) (D) Calibration curves for 
DNA amplified in solution (termed Typical PCR, in gray) and DNA amplified directly off 
microparticle surface (termed Direct PCR, in black). Figures adapted and modified from KR 





microparticles for direct DNA extraction and amplification by performing PCR 
directly at the surface of the microparticles.  
The main drawback from whole chitosan microparticles is the poor PCR 
efficiency when compared to typical, solution-based PCR; for a given 
concentration of DNA, there is roughly a 6-7 cycle delay between the typical 
PCR control and microparticle-based amplification (termed direct PCR, 
Figure 2.2D). We hypothesize that this arises from how the whole chitosan 
microparticles are fabricated, where chitosan is crosslinked together using 
glutaraldehyde. When the DNA is bound to the microparticle, it is deeply 
embedded within the matrix, preventing access of the polymerase to certain 
regions of template. Additionally, whole chitosan microparticles cannot be 
leveraged towards a one-step cell lysis and DNA extraction approach; these 
microparticles lack a solid core, and therefore, they rupture even during gentle 
agitation when binding with DNA in solution and lack the robustness required 
for cell lysis. Between the lower limit of detection due to the cycle delay and the 
fragility of the microparticles, the chitosan microparticle platform must be 
restructured and redesigned for improved direct PCR performance and 
robustness. The continuation of this work will be discussed in Chapter 3. 
2.3 Nucleic acid sequence amplification and detection 
The earliest examples of nucleic acid amplification can be dated to the 
early 1960s49 with the use of in situ DNA hybridization assays. The Southern 
blot is one of the most popular of these methods. First conceived in 1975,50 the 





endonucleases, separating the fragments with gel electrophoresis, transferring 
the products to a cellulose nitrate strip, and lastly labeling with radioactive RNA 
downstream for direct visualization of the fragments. Since then, hybridization 
assays have evolved into dot blot assays – involving the direct deposition of 
target DNA and thus, eliminating the need for fragmentation and separation51 
– and then into the modern-day DNA microarrays, which leverages direct 
labeling of target DNAs or RNAs with a fluorophore (Figure 2.3).  
These assays involve multiple steps that require technical expertise, 
such as blocking the substrate to minimize nonspecific adsorption, adding 
reagents such that concentration gradients are minimized, and washing of 
excess target sequences. Additionally, the sensitivity and limits of detection are 
largely dependent on the complementarity of the target DNA to the capture 
oligonucleotides, the thermodynamic stability of these probes,52 as well as the 
labeling mechanism for detection.49  Detection has been previously 
demonstrated with radiolabeling,50,53,54 chemiluminescence,55–57 and 
fluorescence.58,59 However, all of these methods of detection are measures of 
single binding event, where one binding event leads to a proportional number 
of detection events. For POC applications where low copy detection is 
necessary, often hybridization assays are limited in their sensitivity and limit of 
Figure 2.3. DNA microarrays. Following isolation of target nucleic acids, a labeling kit is 
used to conjugate a fluorophore to the end of the target. This enables visualization following 





detection thresholds. As a result, diagnostic technologies have looked to 
increase the number of DNA molecules produced from a single binding event, 
such that when coupled to detection methods, like fluorescence, we can 
achieve much lower sensitivities than traditional hybridization assays. The 
following sections highlight the evolution of gold-standard methods for nucleic 
acid amplification, the limitations of these methods, and existing alternatives 
that address the needs for POC NAATs.  
2.3.1 Polymerase chain reaction (PCR) 
Polymerase chain reaction, or PCR, is a sensitive assay where 
single-copy limits of detection can be realized. First realized in 1985,60 PCR 
first involved using Klenow polymerase, a thermolabile polymerase from E. coli, 
to amplify short gene-specific sequences of DNA by cycling between 
temperatures repeatedly. Because of the repeated melt step required to 
denature DNA, enzyme needed to be added to the reaction every cycle. 
However, shortly thereafter, DNA polymerase from T. aquaticus (Taq 
polymerase) was discovered to be a thermostable alternative61 and  can survive 
extended incubation at 95 °C. This led to the standard PCR reaction that is still 
in use today: these reactions require having an excess of primers, DNA 
sequences that are complimentary to an 18 – 25 base-pair region of the target 
that are extended by the polymerase to create copies of the template, or 
amplicons. With multiple cycles of heating and cooling – duplex melting and 





especially useful for applications requiring low-copy detection,62,63 which would 
otherwise be impossible using a hybridization assay.   
PCR is only suitable for DNA templates, as they do not degrade at high 
temperatures.  For RNA targets, an additional step is required, involving the 
use of a reverse transcriptase (RT). Originating from retroviruses,64,65 reverse 
transcriptase historically converts the viral RNA genome into a complementary 
DNA (cDNA) to enable integration into the host genome. By using this enzyme 
in conjunction with PCR for RNA analyses, the RNA sequences of interest can 
serve as a template with a universal set of primers to create cDNA, which can 
be later quantified with the approaches outlined in the next section. This 
remains to be the most popular method of low copy RNA quantification for gene 
expression studies, and has since been extended to other RNA targets, such 
as circulating RNA,66–68 RNA viruses,69–71 and microRNA (miRNA).72–74 
Because the RT step for RNA quantification involves an enzyme with differing 
operating conditions than the Taq polymerase and a different set of primers, 
historically this step has been done separately prior to PCR and therefore 
increases the technical expertise and assay time for these tests. As diagnostic 
Figure 2.4. Polymerase Chain Reaction (PCR). (A) PCR consists of cycling among three 
steps: melt to denature the DNA, anneal for primer binding, and extend to polymerize the 
primers to create copies of the sequence of interest. (B) With each cycle, the amount of 
products double so that at the end of n cycles, there are 2n copies more than the starting 





assays have modernized, one-step RT-PCR have been developed to leverage 
the use of gene-specific primers, and thus enable a one-pot reaction for both 
steps of the assay; however this also increases the likelihood of primer-dimers 
and nonspecific product formation,75 and compromises sensitivity and limit 
of detection. 
2.3.1.1 Quantitative PCR (qPCR) and Taqman PCR 
With the development of quantitative or real-time PCR (qPCR), PCR 
technology quickly became a more powerful tool as it was no longer hindered 
by post-processing for the detection of amplicons (i.e. gel electrophoresis). 
Because qPCR allows for simultaneous product synthesis and measurement, 
it is attractive for diagnostic applications. The first approach used the DNA 
binding dye, ethidium bromide, where in the absence of double-stranded DNA, 
there is no fluorescent signal but in its presence, the dye binds between the 
DNA grooves or bases and produces a fluorescent signal.76 As more product 
is synthesized, the fluorescent signal increases; by defining a fluorescence 
threshold, the amount of DNA in the original sample can be quantified based 
on the time taken to reach the given intensity. However, because DNA binding 
dyes target all DNA present, this method does not lend to specificity in 
detection. Often, nonspecific amplification can occur for two main reasons: the 
first being the amplification of dimerized primers, and the second being the 
result of primers binding to other sequences in the target, known as off-target 
amplification. As a result, the amplification of either primer-dimers or off-target 





dyes, as a result, will also fluoresce with these nonspecific products, and 
provide inaccurate quantification. For applications where multiplexed detection 
is necessary, DNA binding dyes do not provide specific quantification 
information as it measures the total DNA being produced. As a result, DNA 
binding dyes are often not used for multiplexing, unless spatial multiplexing is 
incorporated. Since the original publication, other DNA binding dyes have been 
developed specifically for PCR applications, such as the SYBR dyes77,78 and 
other cyanine dyes,79,80 to address assay inhibition that is characteristic of older 
DNA binding dyes. 
A more specific approach can be employed with Taqman PCR (also 
referred to as a nuclease assay), in which a “probe” sequence is introduced to 
the reaction that hybridizes with the target downstream of a primer region. This 
probe leverages Förster resonance energy transfer, or FRET, as one end is 
conjugated to a fluorophore – the donor molecule – and the other end is 
conjugated to a fluorescence-quenching molecule – the acceptor molecule. In 
its intact form, no fluorescent signal is generated from the donor due to the 
proximity of the two molecules. However, as the polymerase synthesizes new 
DNA, the nuclease activity of the polymerase degrades the probe, separating 
the fluorophore and the quenching molecule and thereby resulting in the 
emission of the donor fluorophore.81 Because this signal is generated only if 
the exact target sequence is replicated, rather than if any sequence is 
replicated, Taqman PCR adds specificity and multiplexing to the assay that can 





the most attractive method for applications requiring high specificity. Examples 
of developed Taqman PCR assays for diagnostics include the quantification of 
fetal DNA from maternal plasma for noninvasive prenatal diagnostics,82 and 
implementation in Cepheid’s XPert®, a Taqman PCR system developed 
specifically for low-resource settings, towards the identification of the Ebola 
viral strains.83 
2.3.1.2 Limitations of PCR for POC diagnostics  
 Given the prevalence of PCR for laboratory testing, it has naturally 
become one of the first molecular amplification systems translated for 
near-patient settings. Microfluidic systems have demonstrated significant 
strides in miniaturizing PCR systems, effectively reducing the sample volume 
required by discretizing the sample into droplets and decreasing assay times 
by improving the thermal kinetics. However, these systems require bulky 
peripheral instrumentation, such as syringe pumps required for sample 
discretization, and user intervention. As a result, commercial PCR systems for 
POC settings still test larger volumes. Another important aspect to note is the 
cost and speed limitations of these integrated systems. The Cepheid XPert is 
one of the most widely-used systems for PCR NAATs, integrating sample 
preparation, amplification, and detection. However, because of the complex 
hardware and valve integration required for buffer exchanges and fluid 
transport, these systems can be too expensive for near-patient settings (the 
overall system being roughly $17,000 with each test-specific cartridge at 





systems have high power demands in order to cycle between temperatures. 
While cost and power constraints are not limiting factors for POC environments 
like doctors’ offices, integrated platforms like the Cephied XPert still have assay 
times close to an hour. In these environments, the need for faster assays is the 
driving factor for POC NAAT development. For environments such as 
resource-limited settings, a POC NAAT needs to be cost-effective, cheap, and 
robust. To truly bring NAATs closer to the bedside, novel amplification methods 
that can address speed, while also moving away from thermocycling-driven 
amplification, would make these tests more accessible in a variety of 
near-patient environments. The following sections outline several developed 
isothermal amplification schemes, and how they compare to PCR for POC 
settings. 
2.3.2 Developed isothermal amplification schemes  
 As mentioned previously, the sophisticated instrumentation required to 
cycle between 2 – 3 temperatures requires complex design and power 
constraints for any POC device. To minimize the footprint of these devices, 
significant efforts have been focused on assays that operate at a single 
temperature, known as isothermal amplification schemes, to eliminate the need 
for temperature-dependent melting and annealing of nucleic acids. This section 
aims to illustrate these novel polymerase-driven amplification schemes, and to 
discuss their advantages and limitations towards applying these methodologies 





2.3.2.1 Non-polymerase driven isothermal amplification schemes 
One of the main limitations for any enzyme-based amplification is to 
ensure the activity of the polymerase. As a result, there is often an incorporated 
“hot start” step,85 to melt off either aptamers,86 proteins,87 or wax88 that prevents 
activity of the enzyme during reaction preparation, or it requires cold transport 
or lyophilization of reaction components to ensure the enzyme’s function. 
Another consideration for any enzyme-driven amplification scheme is its 
robustness against inhibitors that are normally present in crude samples. Often, 
these enzymes are highly sensitive to these inhibitors, and require that the 
sample be purified in order to maintain optimal function. Therefore, these 
assays require rigorous sample preparation to ensure that inhibitors such as 
heme from blood,89 urea from urine,90 etc. are not introduced into the assay. 
Because of these limitations, there are some amplification schemes that aim to 
eliminate enzymes all together, and rely on using synthetic nucleic acid 
sequences to achieve transduction.  
Hybridization chain reaction (HCR) is a popular enzyme-free 
amplification scheme that leverages single stranded DNA sequences designed 
to self-assemble into more complex structures at room temperature. The 
assembly of these structures is driven by the free energy of base pairs, and are 
designed such that the synthetic sequences do not hybridize – and thereby 
start the amplification reaction – until the addition of the target DNA. As a result, 





heaters, thermocyclers) is required and can be easily implemented in most 
POC settings. 
HCR involves the design of two hairpins with small loops, which act as 
a kinetic trap given the stability of the structure.91 The addition of the target 
sequence triggers strand displacement in the hairpins, and allows them to bind 
together to form a larger complex, analogous to polymerization in an enzyme-
based amplification scheme. This continuous hybridization occurs until the two 
hairpins are entirely incorporated into these “polymerized” structures 
(Figure 2.5). Because HCR is a linear amplification scheme, in which there is a 
proportional amount of signal produced in relation to the amount of target 
added, the reaction times needed for low concentrations are on the scale of 
hours. As a result, several nonlinear HCR methods have been developed; 
examples of this involve triggering the self-assembly of dendritic DNA super 
structures,92 and increasing the amount of hairpins to produce concatenated 
structures – termed hyperbranched HCR.93  Both of these HCR methods result 
in quadratic, if not exponential, signal amplification, and therefore achieve high 
sensitivity with high specificity.94 However the design of these additional hairpin 
monomers for both dendritic and hyperbranched HCR are equally complex, and 
present another barrier towards wide use of HCR systems. 
Because HCR is very dependent on strand displacement via toe hold 
exchange, and the stability of the stems that form the hairpin, these are critical 
parameters in designing the assay. Any small variation in the hairpins can 





hairpins where the hairpins begin to nonspecifically hybridize and start 
amplification. Despite design constraints placed on GC content, toe-hold 
length, and stem lengths, any variation in temperature can cause shifts in the 
thermodynamic equilibrium and also negatively impact the assay. Between 
these design constraints and the poor sensitivity of HCR, this enzyme-free 
method is limited to laboratory use, or is coupled with other linear enzymatic 
amplification schemes95,96 in order to achieve the desired limit of detection. 
2.3.2.2 Polymerase-driven isothermal amplification schemes 
2.3.2.2.1 Loop-mediated isothermal amplification (LAMP) 
To address the issue of thermocycling, one isothermal method that has 
been developed is loop-mediated isothermal amplification, or LAMP, where 
DNA is amplified continuously with high specificity at a constant 65 °C in under 
an hour. Briefly, LAMP leverages 4 – 6 primers that are specific to 6 – 8 regions 
Figure 2.5. Hybridization chain reaction (HCR). Hairpins H1 and H2 contain stems that act as 
kinetic traps, and do not interact with one another. Only upon addition of the target DNA does 
toe-hold exchange begin, first opening H1 and linearizing the hairpin. Because H2 contains 
an overhang that is complementary to newly linearized H1, toe-hold exchange will occur again 
allow H2 to hybridize to H1. These structures continue to participate in toe-hold exchange and 





of the target, respectively. These primers either serve to create loops, which 
can act as primer binding sites downstream, or to act as bump primers, that 
facilitate strand displacement to produce amplicons. The first round of 
amplification produces a dumbbell-like structure with two loops on either end 
as the starting material (Figure 2.6A, orange structure). These loops contain 
primer binding and extension sites that continue amplicon generation with 
increasing loop structures to feedback into the amplification scheme (Figure 
2.6B). The final products range in size as a result of the various primer 
annealing combinations, and consequently, this method of DNA amplification 
allows for low limits of detection. The first publication of this method was shown 
Figure 2.6. Loop-mediated isothermal amplification (LAMP). (A) Four core primers, termed 
bump primers and inner primers, target six regions of the template. The inner primers consist 
of a sequence that hybridizes to either B2 or F2, and contains an overhang with B1c or F1c. 
Upon extension of the primer, the newly formed DNA will create either B1 or F1, thereby 
allowing the overhang to hybridize and form a loop. Because this scheme employs strand-
displacing enzymes, bump primers targeting B3 or F3 serve to push the amplicon off the 
template to allow for additional primers to anneal and extend.  This results in the formation 
of a dumbbell structure (orange structure, A, or purple dumbbell, B) that yields further 
concatenations to produce higher molecular weight products for detection (B) with either 





to be able to detect as few as six copies of hepatitis B viral DNA.97 By 
eliminating the need for themocycling by having a single operating temperature, 
and leveraging four to six primers with a high amount of polymerase, LAMP 
assays can enable single copy detection within 30 minutes,98,99 significantly 
reducing assay times that are characteristic of PCR.  
            LAMP has since become a widely recognized amplification scheme 
specifically for POC applications due to the simpler instrumentation required 
for detection. With LAMP, thermocyclers are no longer required and detection 
methods can extend beyond using intercalating dyes, through methods such 
as calcein fluorescence in the presence of by-products of nucleic acid 
polymerization or turbidity of the reaction volume due to the high concentration 
of generated DNA.100 Additionally, LAMP has been used in microfluidic devices, 
in conjunction with a reverse transcriptase step, for the detection of HIV RNA 
and achieved a detection limit of fewer than 10 copies of RNA with a run time 
of one hour.101 Despite the advantages of LAMP, this amplification scheme 
requires a constant temperature of 65 °C, and therefore requires more power 
than isothermal amplification systems which operate at 37 °C. Some reports 
have utilized chemical heating (inspired by hand warmers) along with 
engineered phase-changing materials to maintain a constant 65 °C for the 
duration of the reaction without consuming electricity.102–104 Additionally, the 
assay is entirely dependent on the complex design and specificity of the four 
primers involved and therefore, any mismatch will significantly impact the 





rate of false positives106 as the four to six primers involved can form secondary 
structures and consequently, nonspecific extension sites; researchers have 
been able to address this with the use of molecular beacons for additional 
specificity, however for a POC application, this would also increase the cost of 
a device. 
2.3.2.2.2 Exponential Amplification Reaction (EXPAR) 
Another isothermal method that has leveraged strand-displacing 
polymerases is the exponential amplification reaction or EXPAR. EXPAR 
produces exponential signal generation by leveraging the instability of short 
duplexed DNA at higher operating temperatures.107 Briefly, a target will bind to 
a template and be extended. Upon extension, a nicking enzyme will recognize 
the newly-formed duplexed DNA and create a cut on the produced amplicon. 
Due to the thermal instability, the short DNA will melt off of the template, and 
facilitate the cycle of extension, nicking, and melting to exponentially produce 
amplicons. Because of the simple template design, exponential amplification 
can be achieved either by direct EXPAR or copy EXPAR. Direct EXPAR 
involves a symmetric template where complementary target sequences flank 
the recognition site of the nicking enzyme. Upon extension of the target, a 
target analog is created and released upon nicking. This newly released analog 
can then bind to another template and continue the amplification reaction 
(Figure 2.7A). However, with copy EXPAR, two templates are designed: the 
target binding to the first template will create a secondary trigger sequence that 





template, where two complements to the trigger flank the nicking enzyme’s 
recognition sequence. Once the trigger binds, exponential amplification will 
occur as it does with direct EXPAR, but is driven by the products of the first 
amplification reaction (Figure 2.7B). 
Because EXPAR is highly sequence-dependent and is well suited for 
short oligonucleotides, it has been utilized heavily in miRNA detection given the 
many mutations present in a family of miRNA, and the advantage of direct 
amplification instead of a two-step amplification scheme (RT-PCR). Since the 
original publication, the simple design of EXPAR has been leveraged and 
redesigned for miRNA to discriminate let7a variants,108 where variants that had 
Figure 2.7. Exponential amplification reaction (EXPAR). (A) Direct EXPAR employs a 
symmetric template that contains the reverse complement sequence of the target DNA 
flanking either side of nicking enzyme recognition sequence. Upon binding of the target (a), 
the polymerase (green ) extends the target to form a duplex (b). The nicking enzyme (brown) 
then recognizes the double-stranded duplex and its recognition sequence, and cuts the 
upper strand (c). Due to thermostability, the short DNA melts off the duplex (d), which leads 
to it binding to a new template (e) and continuing the process of extension and nicking (c). 
(B) Similar to direct EXPAR, copy EXPAR is a two template system, where the first template 
only contains one copy of the reverse complement to the target (a). Extension and nicking 
of enzyme (b, c) leads to the creation of a new amplicon that participates in direct EXPAR 
with the second template (d). Here, the new amplicon produces analogous products via 






mutations towards the 3’ end of sequence (where extension of the miRNA 
would occur) amplified significantly later than the perfect complement. Given 
its robust amplification efficiency for miRNA, FRET-based hairpin probes, 
quantum-dot conjugates,109 and gold nanoparticles with surface-enhanced 
Raman spectroscopy110 have been leveraged to achieve multiplexed detection 
with EXPAR. Across the various types of detection and reporter methods for 
EXPAR, detection limits ranging from sub-femtomolar to 100 fM can be 
achieved.111 
The main challenge in realizing a POC NAAT that utilizes EXPAR is the 
high nonspecific background signals when multiplex detection is involved. In 
traditional amplification schemes such as PCR, the target acts as the template 
where primers recognize the template to begin extension; however with 
EXPAR, the target instead acts as the primer upon binding to the template to 
begin the amplification reaction. As a result, for low target concentrations, there 
is a higher chance of DNA synthesis in the absence of primers,112,113 which is 
exacerbated in the presence of a nicking enzyme,114 and thus contributes to 
both a high background signal and nonspecific amplification. In addition, when 
designing multiple templates for multiplex detection, there is a higher chance 
of nonspecific interactions between the different templates which would result 
in additional extensions to generate nonspecific products. There are several 
ways to mitigate the nonspecific background signal, such as using a WarmStart 
polymerase,115 using copy EXPAR instead of direct EXPAR,116 minimizing the 





tetramethylammonium chloride (TMAC) or trehalose;117  however some of 
these approaches simply delay the onset of nonspecific amplification by five to 
ten minutes, without eliminating it entirely.117 As a result, limits of detection, 
sensitivity and specificity can be severely hindered in a multiplexed reaction, 
and would rely on spatial multiplexing for detection. 
2.3.2.2.3 Rolling Circle Amplification (RCA) 
Rolling circle amplification (RCA) provides a simple and efficient 
isothermal method of amplification that is amenable to both DNA and RNA 
targets. Building on the work of Nilsson et al., the target acts as a primer that 
binds with a padlock probe, a DNA sequence that has two complementary sites 
to the target (Figure 2.8A). Upon hybridization, a ligase acts on the probe and 
joins to the two ends, effectively circularizing the probe and creating a template. 
By having two complementary sites to the target, this adds specificity to the 
reaction, especially for targets that may have single nucleotide variations as 
mismatched ends of the probe are poor candidates for efficient ligation.118 
However, this early work relied on gel electrophoresis to differentiate ligated 
probes from unligated probes. Additionally, due to the single conversion ratio 
of the padlock to the circularized form, this ligation method was only suitable 
for targets that are in high concentration. RCA addresses the need for lower 
sensitivity with the incorporation of a polymerase in addition to the padlock 
probe and ligation. Inspired by rolling circle replication, the method that bacteria 
use to replicate plasmids, the polymerase acts on the primer following ligation 





of high molecular weight (Figure 2.8B).119 Each amplicon will contain repeats 
of the template’s complementary sequence, which can be leveraged for 
downstream product verification either with restriction enzymes that are 
sequence-specific, or with the use of molecular beacons.  
Because RCA, as outlined above, requires assay times on the order of 
hours due to its linear nature, augmented methods of RCA have been 
developed to address the need for nonlinear amplification to achieve higher 
sensitivities and lower limits of detection. One such method, multiprimed RCA, 
involves having multiple primer binding sites on the circularized template 
(Figure 2.8C). As a result, multiple amplification products can be generated 
upon binding to a single circle. Another variation of exponential RCA is 
hyperbranched RCA, where multiple primers are designed to be 
complementary to the generated RCA product (Figure 2.8D). Similarly, the 
same exponential signal generation can be achieve with designing multiple 
circles that recognize the generated RCA product (Figure 2.8E). With the 
incorporation of the nicking enzyme recognition sequence, the amplicon can 






Because of the facile sequence design, low operating temperature of 
37 °C, and easy implementation, RCA is a popular isothermal method for a 
variety of applications, one of which is miRNA detection. The small lengths of 
miRNA again make it an ideal candidate for both a ligation template, and a 
primer for polymerization. Many groups have presented augmented RCA 
methods to achieve the sensitivities required for miRNA. While the early reports 
for miRNA detection involved traditional RCA120 and hyperbranched RCA,121 
these methods succumb to the challenges of realizing RCA for practical 
Figure 2.8. Rolling Circle Amplification (RCA). (A) depicts the creating of circular templates, 
where a ligation template (black) recognizes to the two complementary arms of the padlock 
probe. Upon hybridization, ligase joins the ends of the padlock, circularizing the probe. (B) 
RCA takes place once a primer (red) hybridizes the probe. The polymerase recognizes the 
free 3’ end and begins templating along the circle. Once it has made a full turn, it’ll displace 
the polymerized amplicon and continue synthesizing DNA. (C) Multiprimed RCA. Multiple 
primers hybridize to the circularized template, providing more extension sites for exponential 
amplification. (D) Hyperbranched RCA: Secondary primers are designed to hybridize to the 
generated amplicon, providing another avenue for exponential amplification. (E) 
Hyperbranched RCA: Secondary circular templates hybridize to the generated amplicon. 






biosensing purposes; specifically, the ligation reaction required for 
circularization often leads to linear multimeric secondary products122 and 
consequently require purification, or requires strict optimizations for the 
enzymes involved in the reaction121 to minimize nonspecific amplification. To 
circumvent these issues, more recent RCA strategies have utilized pre-
circularized templates, where in the absence of the target, are a dumbbell 
structure. These specialized dumbbell templates only become circularized 
when bound to the perfect miRNA complement,123 or once ligated, still maintain 
their dumbbell structure in order to produce secondary double-stranded 
structures in the amplicon, thus enabling real-time detection with the use of 
DNA binding dyes.124 With these specialized dumbbell templates, limits of 
detection range from subfemtomolar to single femtomolar concentrations. 
Despite these advances, there are few published reports that leverage 
exponential RCA for multiplexed detection. Possible limitations of RCA for 
applications requiring multiplexing involve the design of multiple templates or 
multiple primers for each target of interest. In a single-tube reaction, it is 
imperative that none of the templates or primers nonspecifically hybridize to 
create extension sites for the polymerase to act. Additionally, multiplex 
detection would rely on the use of molecular beacons, which come with their 
own design burdens. As a result, exponential RCA would be limited to spatial 






2.3.2.2.4 Nucleic acid sequence-based amplification (NASBA) 
 The last amplification scheme that will be discussed involves the 
sequence-dependent nature of RNA polymerase transcription. Nucleic acid 
sequence-based amplification (NASBA), also known as self-sustained 
sequence replication (3SR), was specifically developed to allow for the direct 
detection of RNA sequences, as an alternative to multistep RT-qPCR methods. 
NASBA mimics the in vivo retroviral replication of an RNA template, by using 
three enzymes and two primers to achieve exponential product generation.125 
Here, the RNA target acts as the template and primer binding site to begin the 
reaction (Figure 2.9A). Upon binding of the first primer, which contains the 
sense sequence of the RNA polymerase promoter, reverse transcriptase will 
act on the 3’ end of the primer and begin extending it. Following extension, the 
RNA is removed with the use of RNase H, freeing the newly synthesized DNA 
to acts a template to continue the reaction. A second primer then hybridizes 
and is extended of the synthesized DNA, now creating a duplexed promoter. 
The double-stranded promoter then initiates transcription with the RNA 
polymerase, a sequence-specific enzyme that only acts upon a duplexed 
promoter. Transcription of the duplexed DNA creates RNA that can feed back 
into the reaction, leading to exponential generation of RNA (Figure 2.9B). This 
RNA can be quantified with traditional methods such as gel electrophoresis, or 
more commonly, with molecular beacons126 specific to the generated RNA 





 Because NASBA enables the real-time detection of RNA within a 
single-tube reaction operated a single temperature, it has been employed since 
the 1990’s for the quantification of viral127–131 and bacterial132–134 RNA targets. 
Since then, the RNA targets tested have expanded to include genomic, 
messenger (mRNA), ribosomal (rRNA) and transfer-messenger RNA (tmRNA) 
targets. Since its creation in the early 1990s, it has been commercialized by 
Organon Teknika (now owned by Biomerieux), where all buffer and enzyme 
Figure 2.9. Nucleic acid sequence-based amplification (NASBA). (A) Linear phase: An RNA 
target first hybridizes with Primer 1. Primer 1 consists of an overhang that encodes for the 
T7 promoter. Reverse transcriptase recognizes the free 3’ end and extends Primer 1. 
RNase H, an enzyme that selectively degrades RNA, proceeds to remove the target to then 
allow Primer 2 to hybridize the remaining DNA strand. Reverse transcriptase extends Primer 
2, thus producing a full duplex containing the double-stranded promoter. T7 RNA polymerase 
then recognizes the double-stranded promoter, and produces antisense (RNA (+)) analogs 
of the initial RNA target. (B) Exponential phase: RNA (+) strands feedback into the system 
as they can first hybridize with Primer 2. Similar to the linear phase, the primer is extended 
and RNase H acts on the RNA transcript by degrading it. Primer 1 then binds to the remaining 
DNA. Because there are now two free 3’ ends, polymerization by the reverse transcriptase 
leads to the full duplex, and again the double-stranded promoter. This further produces RNA 





components are available as part of the NucliSENS Basic Kit, and primers and  
molecular beacon probes specific to the intended target are purchased 
separately.135 Targets range from rRNA targets for bacterial identification, 
mRNA specific to the translation of proteins (such as gp105 mRNA for 
identification of human herpes virus 6), and non-coding regions135 or 
group-specific antigen genes136 of viral genomes. With the partnering sample 
preparation and DNA extraction platforms as well as the custom amplification 
and detection instrumentation, this NucliSENS kits have demonstrated 
sample-to-answer times of roughly 4 hours when assaying 24 samples.137 
Additionally, several studies have shown that NASBA performs similarly to 
existing commercial Taqman PCR assays, enabling the adoption of this 
platform in central labs where specific diseases of interest are highly 
prevalent.138 Again, because the modules of sample preparation and DNA 
amplification are highly dependent on the availability of refrigeration and access 
to a power source, the NucliSENS platforms are again tethered to the central 
lab. Previously, CorisBioConcept leveraged NASBA for the identification of 
Leishmania and T. Cruzi using lateral flow tests for detection.139 These assays 
normally took roughly 90 minutes to run, and cost about $26 per test. However, 
this company now focuses solely on dipstick-based assays that no longer 
require amplification beforehand and thus, no longer provides these products. 






 Overall, NASBA provides a sensitive and robust method for direct 
detection of RNA targets. By leveraging the target as the hybridization template 
for primers downstream, it reduces the chance of off-target amplification and 
transcription. However, there have been several reports suggesting that for 
certain disease targets, NASBA does not provide the necessary specificity as 
compared to traditional PCR tests.140 This is in part due to early stage 
amplification that occurs due to the nonspecific transcription of dimerized 
primers, specifically those where the T7 RNA polymerase promoter region is 
included.141 As a result, extra care must be taken when designing primers and 
molecular beacons for these assays, as any nonspecific hybridization will 
inevitably lead to a high background signal, or worse a false-positive result. 
2.3.3 Outlook for DNA amplification methods 
With the directed evolution Taq polymerase and the specificity brought 
by sequence-specific binding of targets, PCR and its derivatives for other 
nucleic acid targets have offered sensitive detection, often with a wide dynamic 
range and low limits of detection. However, as the diagnostic community aims 
to bring these assays outside of the central laboratory, the temperature-driven 
model of amplification falls short due to the instrumentation constraints of these 
near-patient settings. Significant progress has been made towards the 
development of isothermal amplification schemes for both RNA and DNA 
targets alike. While PCR is often criticized for its instrumentation burdens, PCR 
offers the advantages of having specific activity with the use of hot-start 





extension of primers and the activity of Taq polymerase. While the 
aforementioned isothermal schemes that are presented as improved 
alternatives to PCR, often they present new design challenges due to the 
constant activity of these enzymes at a single temperature. As a result, most of 
these schemes suffer from some form of nonspecific amplification, either 
caused by the robust activity of the polymerases involved, or unintended 
hybridization that leads to additional extensions sites on which the polymerase 
recognize. Additionally, these schemes are heavily reliant on DNA binding 
dyes, which do not differentiate on-target versus off-target amplification. 
Therefore, novel detection methods to achieve multiplex detection, as well as 
insights towards achieving specific amplification in an assay need to be 
expanded to better inform assay design and translation towards an integrated 
device. Chapters 4 and 5 aim to address these issues where we assess a 
previously reported probe-based method towards multiplex detection of three 
MRSA genes, and we evaluate different design considerations towards the 
development of a novel amplification scheme specific to microRNA targets, 






Chapter 3. Simplifying nucleic acid amplification from whole blood 
with direct PCR on chitosan microparticles1 
 
3.1 Introduction 
NAATs, in particular PCR, are commonly used in diagnostics as 
discussed in Chapter 2, including inherited diseases, cancer, and infectious 
diseases.  In recent years, an extraordinary amount of research and 
development has been directed at the transition from central lab PCR tests to 
near-patient NAATs.  The first demonstrations of microfluidic PCR date back 
nearly 25 years;142,143 recent review articles report numerous demonstrations 
of miniaturized PCR144,145 and isothermal NAATs146 that target near-patient 
applications.   
While PCR and other NAATs have been successfully miniaturized, the 
amplification reaction and signal measurement are not the most challenging 
components to implement in a near-patient or low-resource setting.  In reality, 
the sample processing steps present the steepest challenges, especially for 
diagnostic assays aiming to achieve the cost targets and the regulatory 
clearance for near-patient use.  Traditionally, nucleic acid purification is carried 
out using a solid phase extraction technique.147  The most commonly used 
commercially available format is a spin column with a silica membrane 
                                            





designed for use with a centrifuge. First, DNA is liberated from cells using a 
lysis buffer.  Then, binding, washing, and elution solutions are driven through 
the column in series by centrifugal force. Chaotropic salts in the lysis buffer 
drive adsorption to the silica. Alcohol is then used to wash away the salts and 
cellular debris, which would otherwise inhibit PCR. Finally, purified nucleic 
acids are eluted into a moderate salt buffer.    
The high number of hands-on precise steps in this approach prevent it 
from being carried out in a near-patient setting.  Using magnetic silica 
microparticles for lysis and solid phase extraction limits the reliance on a 
centrifuge, thus enabling the opportunity for automation.  With this approach, 
one can utilize a robotics-assisted system to perform some sample preparation 
steps, but this is still not appropriate for near-patient applications.  Over the last 
decade, several reports have demonstrated integrated sample preparation with 
PCR in microsystems by mimicking the solid phase extraction and elution steps 
in a microfluidic format;148–156 however, because of the number of steps 
required, the microsystems tend to be somewhat complicated and require 
external equipment to run, thus making them too costly and in some cases too 
cumbersome for near-patient use.  This is true for commercial point-of-care 
platforms as well, such as the Cepheid XPert®, the Roche cobas® LIAT 
system, and the Atlas io™. While these are integrated systems that allow for 
sample-to-analysis detection, they rely on conventional lysis methods (i.e., 
chaotropic salts157–159or sonication160,161) and multi-step solid phase extraction 





reagent additions required in these systems to facilitate binding and elution of 
DNA necessitate sophisticated fluid handling and instrumentation.  More 
promising may be the development of foldable paper systems that mimic the 
many steps of conventional solid phase extraction, though these techniques 
could also benefit from a reduced number of steps to speed the assay, and to 
meet regulatory standards for use outside of a central lab. Ultimately, a new 
methodology that minimizes the number of steps in sample preparation is 
necessary for practical near-patient NAATs, whether they are performed in 
conventional assay tubes/plates, in microsystems, or other novel formats. 
In our previous work we introduced a streamlined approach that we 
termed direct PCR in which nucleic acid sequences are amplified directly off of 
the capture and purification surface, thus avoiding most of the steps in the 
conventional protocol.  Chitosan microparticles were utilized to capture DNA 
and to retain the template during the PCR reaction.  While chitosan has been 
used for DNA purification in a charge-switching approach,162 we showed that, 
in high density, chitosan can capture and retain DNA even well above the pKa 
of the amine groups on the chitosan.  This effect with chitosan has been 
reported previously when designing chitosan systems for drug delivery163,164 
and for microparticle synthesis.165  Upon showing that we could permanently 
capture nucleic acids at a PCR-optimal pH, we showed that the captured DNA 
can be amplified directly from the microparticle surface when the microparticles 





In this work we extend the direct PCR concept to whole blood samples 
(Figure 3.1).  Chitosan-coated magnetic silica microspheres are used to lyse 
cells and to capture the released DNA in a single step.  The microparticles are 
then added to a PCR reaction to amplify the DNA directly from the surface.  We 
show efficient lysis and amplification using an optimized vortexing method; the 
cycle threshold for our approach is only shifted by a few cycles compared to 
typical solution-based PCR.  We also show that avoiding washes entirely 
(which can lead to the simplest near-patient implementation) does not inhibit 
PCR.  Finally, we demonstrate amplification of DNA sequences from whole 
blood samples using our direct PCR approach.  First we show the amplification 
of human genomic DNA released by the cells in a droplet of blood, and then 
we demonstrate the amplification of plasmid DNA (representing circulating 
DNA, e.g., from viruses) spiked into blood droplets. 
 
 
Figure 3.1. Direct PCR. Chitosan-coated silica microparticles lyse cells under vortex and 
capture DNA in the same step. The microparticles are then added to a PCR reaction where 





3.2 Materials and Methods 
3.2.1 Chitosan-coated microparticle fabrication  
Chitosan-coated microparticles were fabricated by reacting epoxides 
present on the surface of modified silica microparticles with the amine groups 
on the chitosan (Figure 3.2A). A stock solution of 1% (w/v) low molecular weight 
chitosan (Sigma) was prepared in a 1% (v/v) acetic acid solution (pH = 3.73). 
Prior to the attachment of chitosan to the microparticle, the stock solution was 
diluted to 0.1% (w/w) low molecular weight chitosan in de-ionized (DI) water 
and brought to pH 9 using 1 M NaOH (Macron).  The moderately high pH is 
necessary for the amine-epoxide reaction; because of the higher pH, the 
chitosan solution must be dilute due to its poor solubility above a pH of 
about 6.5. Epoxide-coated magnetic silica microparticles (600 μL, 10 mg/mL), 
3 µm in diameter (Amsbio), were washed three times in 0.1% (w/w) 
Triton X-100 (Sigma) in DI water. The 0.1% chitosan solution (500 μL) was then 
added to the magnetic microparticles and vortexed overnight. Following 
functionalization, the chitosan-coated microparticles were washed three times 
using 0.1% (w/w) Triton X-100 in DI water and then stored in 10 mM Tris, 0.1% 
(w/w) Triton X-100 (pH 8.5) at a concentration of 50 mg/mL at room 
temperature. Following functionalization, large aggregates of chitosan 
microparticles were present, which were later broken apart during the 
subsequent washing steps. While the individual microparticles have a diameter 
of 3 µm, the majority of the microparticles appear in clusters that range between 





have shown efficient DNA capture and amplification when stored at room 
temperature for up to six weeks. 
 
3.2.2 Direct PCR with purified DNA 
Direct PCR was assessed using plasmid (pBR322, New England 
Biolabs) and human genomic DNA (hgDNA). Purified hgDNA was isolated from 
MCF7 cells (ATCC) using a DNeasy Blood and Tissue Kit (Qiagen) prior to the 
experiments according to the manufacturer’s recommendations. For DNA 
capture, 200 µg of chitosan microparticles were added to 95 µL of loading buffer 
Figure 3.2. Chitosan microparticle fabrication and DNA binding. (A) Magnetic silica 
microparticles are covalently functionalized with chitosan by reacting the epoxide groups on 
the particles to the amine groups on chitosan.  Chitosan-coated microparticles are capable 
of capturing DNA upon mild vortexing.  Bright field and fluorescence images are shown 





(10 mM Tris, 0.1% Triton X-100, pH 8.5), after which 1 µL of DNA diluted in DI 
water was introduced to the solution. The chitosan microparticles were then 
vortexed at the lowest speed for 3 minutes to facilitate DNA capture and were 
then washed once in loading buffer. Figure 3.2 shows bright field and 
fluorescence images of the microparticles before (Figure 3.2B) and after 
(Figure 3.2C) DNA capture. In this qualitative demonstration, 109 copies of 
plasmid DNA were added to 200 µg of chitosan microparticles and immersed 
in a solution of 1x SYBR Green I. DNA is clearly visible on the chitosan-coated 
microparticles after capture (Figure 3.2).  
Immediately following DNA capture, the microparticles were added to a 
PCR reaction. All PCR reactions consisted of 1x iQ SYBR Green Supermix 
(BioRad), 0.25 µM forward primer, and 0.25 µM reverse primer, unless noted 
otherwise. Bubbles present in the PCR reaction were removed with 
centrifugation and qPCR was performed using an MJ MiniOpticon thermal 
cycler (BioRad). The PCR protocol consisted of a 3-minute hot start, followed 
by 35 thermal cycles, which included a 95 °C melt for 15 seconds and a 
combined anneal and extension step (temperatures listed in Table 3.1) for 
30 seconds, unless noted otherwise. Magnets were placed alongside the PCR 
wells during thermocycling to pull the chitosan microparticles to the side to 
minimize interference with the fluorescence measurements. All reported cycle 





Table 3.1. Primer sequences and annealing temperatures for various DNA 
templates (F: forward, R: reverse) 
DNA 
source Primer Sequences 
Anneal 
Temp. 
Plasmid F: 5’ – CAC TAT CGA CTA CGC GAT CA – 3’ R: 5’ – ATG CGT CCG GCG TAG A – 3’ 56 °C 
Human F: 5’ –  TGA GCG CGG CTA CAG CTT –  3’ R: 5’ – TCC TTA ATG TCA CGC ACG ATT T – 3’ (166) 
60 °C (1 
minute) 
 
3.2.3 Human genomic DNA binding capacity 
To investigate the DNA loading capacity of the microparticles, increasing 
amounts of DNA were loaded onto chitosan-coated microparticles as described 
above to yield ratios of 5, 50 and 500 copies of DNA/µg of microparticles 
(500 copies/µg is equivalent to approximately 0.04 human genome copies per 
microparticle). Following DNA capture, microparticles were placed in a PCR 
reaction for qPCR and the cycle threshold was measured for each DNA 
concentration.  We were unable to load higher copies of DNA/µg because 
increasing the number of cells by 10x or decreasing the number of 
microparticles by 10x were both found to be impractical.    
3.2.4 Cell preparation 
MCF7 breast cancer cells were cultured in T25 flasks in DMEM (Life 
Technologies) supplemented with 10% fetal bovine serum (Life Technologies) 
and 1% penicillin-streptomycin (Life Technologies) under standard tissue 
culture conditions.  Cells were subcultured approximately every 5 days. In 
preparation for DNA extraction, MCF7 cells were harvested with trypsin and re-





3.2.5 Cell lysis 
For cell lysis, 10 µL of the cell suspension was added to Tris-Triton buffer 
and 200 µg of chitosan microparticles; this solution was vortexed at moderate 
speed for 3 minutes for simultaneous cell lysis and DNA capture. One wash 
step in loading buffer following DNA capture was performed unless otherwise 
noted.  All heating times and vortexing speeds were carefully optimized based 
on the parameters that led to the lowest qPCR cycle threshold for the 
respective techniques. 
Live/dead staining was used to qualitatively assess both the lysis and 
DNA capture efficiency. A stock solution of live/dead stain containing 4 µM 
ethidium homodimer-2 (Life Technologies) and 5 µM calcein AM (Life 
Technologies) in PBS was prepared. 10 µL of the cell suspension was used for 
each respective experimental sample; the cells were first immersed in 40 µL of 
live/dead stain for 30 minutes and imaged with a fluorescence microscope 
(Olympus IX-51) as a positive control. For the live/dead negative control, cells 
were heat lysed at 95 °C for 15 minutes and then immersed in 40 µL of the 
live/dead stain. The experimental samples were stained and imaged after DNA 
capture. Following DNA capture, chitosan microparticles were stained and 
imaged to assess DNA coverage on the surface. 
Quantitative PCR was used to assess the lysis and DNA capture 
efficiency of direct PCR with cell lysis. 10 µL of the suspended cells underwent 





step, the chitosan microparticles were immediately added to a PCR reaction, 
as described earlier. All qPCR samples were supplemented with 0.2x 
EvaGreen and qPCR was performed for 40 cycles. Two controls were included 
in all experiments: (i) a solution-based PCR with 104 copies of purified MCF7 
DNA (no chitosan microparticles present), noted as typical PCR, and (ii) direct 
PCR with 104 copies of purified DNA loaded onto the chitosan microparticles.  
During preparation, the number of DNA copies was measured using a 
NanoDrop spectrophotometer. 
3.2.6 Direct PCR from a whole blood sample 
A 1.5 mm lancet (BD) was used to collect 1 µL of blood from a fingertip 
and was brought to a 10 µL volume with a 3.2% (w/v) sodium citrate (Sigma) 
solution. Each sample was added to 200 µg of chitosan microparticles in 90 µL 
Tris-Triton buffer (10 mM Tris, 0.5% Triton X-100, pH 8.5). After the samples 
underwent mechanical lysis and one wash in loading buffer, the microparticles 
were immediately placed into a PCR reaction. All PCR reactions were 
supplemented with 0.2x EvaGreen for fluorescent signal enhancement. Direct 
PCR with purified DNA and typical PCR controls were also included. 
3.2.7 Direct PCR of pBR322 in a whole blood sample 
Whole blood was collected using the same procedures as for direct PCR 
from whole blood. 106 or 104 copies of pBR322 DNA were added to the blood 
sample, which was then added to the Tris-Triton buffer and chitosan 





microparticles were then washed once before they were added to a PCR 
reaction, which was supplemented with 0.2x EvaGreen. Direct and typical PCR 
controls using equal amounts of pBR322 were included. 
3.2.8 PCR product validation 
Thermal melt analysis and gel electrophoresis were used to confirm 
PCR products generated from all PCR reactions. The melt analysis was 
included in the PCR programmed protocols following thermal cycling, where 
the fluorescence was measured as the temperature increased from 60 °C to 
95 °C by 0.5 °C increments at a rate of 0.1 °C /s. Afterwards, supernatants from 
all samples were separated on a 2% (w/v) agarose gel containing 1x SYBR 
Green I (Lonza) at 125 V for 45 minutes.   
3.3 Results and Discussion 
3.3.1 Characterization of direct PCR with human genomic DNA 
In our previous work we utilized only plasmid DNA for the 
characterization of direct PCR (capture and amplification directly from the 
chitosan surface).  In order to utilize direct PCR for diagnostics, it is necessary 
to demonstrate that the technique can capture and efficiently amplify relevant 
genomic DNA.  In Figure 3.3 we present the cycle thresholds for direct PCR 
with plasmid DNA and with human genomic DNA.  With both samples, the cycle 
threshold for direct PCR lags the cycle threshold for solution-phase PCR by 
about 4 cycles.  We expect that this threshold cycle difference results from 





PCR reaction prevent much of the bead surface area from being accessed, 
and/or because some of the targeted sequences are bound too tightly within 
the chitosan.  Nonetheless, even with these challenges, which can be 
addressed in future work, this streamlined method enables amplification and 
detection of trace amounts of DNA.  
To assess the binding capacity of the microparticles, increasing 
amounts of human genomic DNA were loaded onto a fixed mass of 
microparticles.  As the copy number of DNA increased, the cycle threshold 
observed for direct PCR decreased as expected (Figure 3.4). Interestingly, a 
negative exponential decay trend can be observed; i.e. the cycle threshold 
difference between 50 and 5 copies/µg of microparticles is about 2 – 3 cycles 
while the difference between 500 and 50 is 1 – 2 cycles. Therefore, the upper 
limit of detection can be approximated to be at least 500 copies of DNA/µg of 
microparticles. While it would be ideal to confirm this explicitly, higher 
concentrations of at least 106 copies of human genomic DNA would be 
unrealistic for PCR applications. 
Figure 3.3. Cycle thresholds with direct and typical PCR for plasmid DNA and human 






3.3.2 Assessment of direct PCR with integrated lysis 
After verifying that the microparticles can capture free DNA from solution 
under vortex and that the DNA can be amplified directly from the surface after 
capture, we investigated their capacity to acquire, purify, and amplify genomic 
DNA directly from complex samples.  First, we verified that vortexing the 
microparticles with intact cells (i.e., bead beating) releases DNA for capture.  
Figure 3.5 presents the visual results with cultured MCF7 cells.  Following lysis, 
very few intact cells can be observed (Figure 3.5C); additionally, DNA is 
released into the supernatant, represented by the red fluorescence evident in 
the supernatant due to the ethidium stain of the released DNA. After the 
addition and separation of chitosan microparticles, the microparticles become 
one large aggregate due to the presence of negatively charged DNA on the 
positively charged microparticle surface (inset of Figure 3.5D). 
 
 
Figure 3.4. Cycle thresholds from direct PCR with 200 µg of chitosan microparticles and 
an increasing amount of purified human genomic DNA loaded onto the surface. Error  






We then assessed the integration of the lysis and direct PCR steps by 
amplifying the DNA captured by microparticles that had lysed cultured MCF7 
cells.  Figure 3.6A presents the real-time PCR amplification curves for direct 
PCR from lysed cells and compares the curves with two controls: direct PCR 
from purified human genomic DNA and solution-phase PCR with purified 
human genomic DNA.  The results show that direct PCR amplification from a 
sample of intact cells performs comparably to direct PCR from purified DNA; 
this demonstrates the potential for simultaneous lysis and immobilization of 
accessible DNA without the use of PCR-inhibiting lysis reagents.  In an attempt 
to improve lysis and capture efficiency, heat (70 °C) was tested to augment 
mechanical agitation. No resulting improvement was found in lysis or 
amplification efficiency (data not shown). As a result, all further experiments 
were conveniently performed at room temperature. 
Figure 3.5. Live/dead staining of cells and supernatants after lysis. (A) Live-cell control of 
MCF7 cells. Green signifies staining with calcein AM (live stain) and red signifies staining 
with ethidium homodimer-2 (dead stain, i.e., nucleic acid stain). (B) Dead-cell control of 
MCF7 cells after being heat lysed at 95 °C for 10 minutes. (C) Supernatant following 
mechanical lysis with chitosan microparticles. (D) Chitosan microparticles from lysed sample 
following separation of microparticles from the supernatant. Inset shows live/dead staining 





After eliminating the need for lysis agents, DNA purification and 
amplification was simplified to three simple steps: vortex, rinse and amplify. 
Motivated by the potential to eliminate extraneous manual involvement that can 
complicate or obviate portable PCR, we sought to eliminate the rinse step 
between lysis and amplification, as a rinse step may be a labor-intensive 
intervention that could prohibit near-patient applications.  We assessed the 
impact of rinses by conducting an increasing number of rinses on parallel 
samples and measuring the difference in cycle threshold.  Figure 3.6B shows 
the cycle threshold for lysis and direct PCR for a range of 0 to 3 rinses.  Even 
with no rinsing, amplification was successful, with a cycle threshold of about 
four cycles higher than the solution-phase PCR.  Further rinsing did not improve 
the cycle threshold.  This demonstrates that in fact the direct PCR approach 
can truly minimize the number of steps in PCR sample preparation. 
 
Figure 3.6. Direct PCR characterization of mechanical lysis method. (A) Amplification curves 
of lysed samples with direct PCR and typical PCR controls with purified DNA of equal copy 
number to experimental samples. (B) Comparison of cycle threshold with increasing washes 
following lysis. All experiments used 104 cells for lysed samples or 104 copies of DNA for 
direct PCR and typical PCR controls. Real-time curves represent the average of three 





3.3.3 Direct PCR from a whole blood sample 
The results above demonstrate that the chitosan-coated microparticles 
can lyse cells to release DNA in a simple bead-beating procedure, that they 
can capture DNA during the lysis step, and that the bound DNA can be 
amplified directly from the surface following minimal washing steps.  Manual 
and precise intervention steps are for the most part eliminated as compared to 
the conventional approach to PCR, suggesting that the direct PCR method may 
enable near-patient diagnostics, even with complex patient samples.  To 
illustrate this further, we utilized a whole blood droplet as the initial sample.  
Approximately 1 μL of whole blood was added to the microparticles in buffer 
and direct PCR (following bead-beating) was performed.  The real-time PCR 
data in Figure 3.7 demonstrate that the amplification curve for a whole blood 
sample is similar to the curve for direct PCR with pre-purified DNA (104 copies), 
and that both curves lag the typical PCR (104 copies) by only 4 cycles.  PCR 
products were confirmed to be the same as those of the typical PCR control 
using melt curve analysis and gel electrophoresis (Figure 3.8). This suggests 
similar performance between the whole blood sample and the purified DNA, as 
we estimate that the whole blood droplet contained approximately 104 cells 
(though the blood droplet volume from the lancet could not be perfectly 
controlled and the number of white blood cells can vary from 5 × 103 to 104 







While this result illustrates applications of the direct PCR method to 
genetic disease diagnostics, today there are more immediate needs for 
near-patient infectious disease diagnostics.  Thus we further investigated 
whether free DNA (e.g., DNA from bloodborne viruses) in blood samples could 
be captured and amplified with the same methodology.  One primary concern 
Figure 3.7. Amplification curves of direct PCR from whole blood samples. Direct and typical 
PCR controls contained 104 copies of DNA.  Curves represent the average of 3 samples.  
The cycle threshold for direct PCR in blood is 26.15, which is about 4 cycles higher than the 
solution phase control (typical PCR). 
Figure 3.8. Confirmation of PCR products from Figure 3.7. (A) Melt curve analyses show 
that the melt temperatures, 82.0 ± 0.5 °C, of the amplicons produced by direct PCR from 
both whole blood and purified DNA match the melt temperature, 82.5 °C, of amplicons 
generated in absence of chitosan microparticles. (B) Direct PCR products run on a 2% 







is whether the microparticles would capture viral DNA despite the large mass 
of human genomic DNA in a blood droplet.  To test this, we used pBR322 
plasmid DNA spiked into blood samples to represent viral DNA circulating in 
blood. 
Real-time PCR data for the amplification of 104 copies of plasmid DNA 
in blood droplets are presented in Figure 3.8.  The amplification data 
demonstrate that the plasmid DNA in whole blood was amplified, despite the 
~104 copies of human genomic DNA in the blood sample.  For comparison, 
Figure 3.8 also presents the amplification control for 104 copies of pure plasmid 
DNA using the direct PCR methodology.  The data illustrate that the presence 
of human genomic DNA introduces a notable, but consistent shift of two cycles 
to reach the threshold for both 104 (Figure 3.9) and 106 (Figure 3.11) copies 
when compared to direct PCR controls with pure plasmid DNA.  These results 
suggest that the direct PCR methodology can be applied both to human genetic 
disease diagnostics and bloodborne infectious disease diagnostics. 
Figure 3.9. Amplification of plasmid DNA (pBR322) in whole blood samples. Direct PCR 
and typical PCR controls contained 104 copies of DNA.  Curves represent the average of 3 
samples.  The cycle threshold for direct PCR of pBR322 in blood is 28.12, which is about 2 
cycles higher than the direct PCR control of pBR322 in buffer and 5 cycles higher than the 









Given the minimal steps required of our direct PCR methodology, 
chitosan microparticles can be utilized to realize a simple and rapid point-of-
care diagnostic. Many research groups have developed microfluidic platforms 
that are amenable to qPCR with a portable fluorescence analyzer for 
quantification.167–169 Since our chitosan microparticles do not require any 
manipulation during amplification, they can easily be integrated into a 
Figure 3.11. Amplification curves of 106 copies of pBR322 in whole blood (black line) and 
without whole blood (gray solid line) in the presence of chitosan microparticles. The dotted 
gray line is of equal copy number in the absence of chitosan microparticles. 
Figure 3.10. Melt curves analysis of PCR products from Figure 3.9. The melt temperatures, 
83.0 ± 0.5 °C, of the amplicons produced by direct PCR from both pBR322 alone and 
pBR322 spiked in whole blood, match the melt temperature, 83.0 °C, of amplicons generated 





microfluidic device or cartridge. Additionally, bead-beating has been 
implemented in a microfluidic platform either with pneumatic vibration for glass 
beads170,171 or by applying a magnetic field to magnetic particles to achieve 
mixing.172–174 Given that our chitosan microparticles are magnetic, this can be 
leveraged as a mechanism for both chaotic mixing and transfer from a DNA 
capture module to an amplification module, without an additional wash step. In 
this format, chitosan microparticles can provide a simple, one-step method for 
sample-to-answer detection of genomic targets. 
3.4 Conclusion 
In this work we have demonstrated a new streamlined method for 
PCR-based diagnostics from complex samples.  Chitosan-coated 
microparticles are able to liberate and bind DNA from human cells under simple 
mechanical agitation; DNA sequences can then be directly amplified from the 
surface of the microparticles.  The required steps for the entire process are 
(i) to agitate the cells with the chitosan-coated microparticles, and (ii) to transfer 
the microparticles to a PCR reaction.  Minimal washing was shown to be 
necessary, thus maintaining a low number of steps.  Real-time PCR showed 
that the cycle threshold for direct PCR from whole blood samples is only a few 
cycles higher than typical solution-based PCR from purified DNA.  We believe 
that this technique has the potential to eliminate all precise intervention steps 
from PCR diagnostics without the need for sophisticated equipment, and thus 
may lead to near-patient diagnostics.  By demonstrating amplification of human 





genetic disease diagnostics, such as newborn screening, cancer risk 
assessment, and future applications in personalized medicine.  Additionally, by 
demonstrating the amplification of spiked plasmid DNA in blood droplets, we 
also highlight applications such as cell-free DNA identification and infectious 
disease diagnostics.  In particular, identification of viral pathogens from a 
droplet of blood using our simple approach offers new opportunities for 







Chapter 4. Demonstration of a quantitative triplex LAMP assay with 
an improved probe-based readout for the detection of MRSA2 
 
4.1 Introduction 
PCR remains at the forefront of molecular diagnostics due to its 
robustness and familiarity over the past three decades. However, PCR is 
hindered by its relatively long assay time and instrumentation complexity due 
to the need to cycle between two to three temperatures. As diagnostic 
technologies aim to bring assays closer to the patient (POC testing) and to 
improve sample-to-answer turnaround, nucleic acid amplification tests are 
slowly moving away from PCR in favor of amplification schemes that operate 
at a single temperature. Consequently, numerous isothermal methods for 
nucleic acid amplification have been developed that have reduced the 
instrumentation demands of precise temperature control, and also achieve 
faster assay times. Of these methods, loop-mediated isothermal amplification 
(LAMP) has become the most pervasive. 
First developed in 2000 by Notomi, et al.,97 LAMP leverages a strand-
displacing polymerase and four core primers that are specific to six regions of 
the template. As the reaction progresses, exponential amplification is achieved 
by the cascading enzymatic generation and subsequent unfolding of synthetic 
                                            





DNA structures, templated along the target sequence. These structures allow 
for the generation of different high molecular weight products, thereby 
facilitating exponential product generation in less than an hour. The multiple 
structures can participate further in the reaction as they have hybridization sites 
that allow the core primers to anneal, extend, and produce more amplicons; as 
a result, LAMP has shown 10-1000 times greater sensitivity as compared to 
PCR.175 The increased speed, sensitivity, and specificity139,176 has made LAMP 
the premier method for isothermal amplification. Since its original report in 
2000, the number of publications related to the development and 
implementation of LAMP has been increasing at an exponential rate.177 These 
publications include diverse applications, including the detection of miRNA 
targets178–180 and viral genomes181–184 with the addition of reverse 
transcriptase, investigation of enzyme inhibition from sample matrices,185–187 
and the implementation into microfluidic devices for point-of-care 
applications.188–190 
As LAMP is often targeted for point-of-care applications, single-reaction 
multiplexing is important to achieve in order to maintain a small device footprint 
and to reduce demands on sample volume. The primary hindrance in realizing 
a LAMP assay for a multiplexed diagnostic remains a robust method for 
real-time detection. Most reported detection methods for LAMP are end-point 
techniques, such as leveraging a colorimetric or fluorescence change upon 
addition of a responsive molecule (i.e. hydroxynaphthol blue191 or 





observe the DNA products generated, or modified primers (i.e. biotinylated or 
conjugated with a fluorophore193,194) for lateral flow detection. These methods 
can provide a simple readout for a positive or negative result; however, 
endpoint measurements are not quantitative for exponential 
amplification assays.  
To address the need for quantitative measurements, two main methods 
have been employed: fluorescence measurements with the addition of an 
intercalator (i.e. SYBR and SYTO dyes) and turbidity. While these methods 
generate signals in real time related to the total amount of DNA in the reaction, 
thus enabling quantification when compared to a standard, they do not provide 
specific information about the sequence being amplified, thus implying a lack 
of specificity and an inability to distinguish between multiple targeted 
sequences amplified simultaneously. As diagnostic technologies progress 
towards more comprehensive assays that test for more than a single 
biomarker, nucleic acid amplification tests are moving away from the indirect 
methods of detection and towards those that are specific to their targets of 
interest. Examples of this for PCR include Taqman PCR and the use of 
molecular beacons; analogous approaches would be an ideal solution for 
multiplexed, quantitative LAMP assays. 
To achieve this, FRET-probe-based methods have been developed, 
including the redesign of the loop primers to act as molecular beacons,175 
fluorogenic bidirectional displacement (FBD) probes,195 and assimilating 





primer regions such that during amplification, the fluorophore- and quencher-
labeled sequences are separated. However, designing and implementing loop 
primers is often complex and is not always possible, which limits the broad 
application of these methods.  Further, the molecular beacon approach 
requires 0.8 M betaine, which is also not generalizable across LAMP assays.   
One of the first probe-based methods for real-time LAMP detection was 
developed by Tanner, et al., known as “detection of amplification by release of 
quenching” (DARQ LAMP, Figure 4.1). Again leveraging the molecular zipper 
design, this approach utilizes a probe that hybridizes to one quenched inner 
primer to form a duplex such that once the polymerase encounters the duplex, 
the probe is displaced and produces a fluorescent signal (Figure 4.1A).199 
Because this duplex targets the inner primer instead of the loop primers, this 
Figure 4.1. Schematic of DARQ LAMP (A) and locations of incorporated QPDs with generated 
amplicons to continue fluorescent measurements (B). Through a series of polymerization, the 
QPD becomes incorporated into the produced amplicons. As the reaction proceeds, the strand-
displacing activity of the polymerase facilitates the probe’s release from the quenched inner 
primer. Because the QPD can become incorporated in later amplicons, DARQ LAMP enables a 





method can be employed for both four- and six-primer LAMP systems. The 
authors demonstrated the multiplexing capabilities by interrogating different 
genomes with individualized primer sets and Bst 2.0. However, since its 
publication, DARQ LAMP has not been widely employed because the quencher 
probe duplex (QPD) has been reported to show amplification inhibition.106,199  
While all of the FRET-based LAMP methods that enabled 
single-reaction multiplexed detection are problematic, DARQ LAMP is the 
simplest and most universal to implement.  However, it requires further study 
to elucidate the optimization factors that can reduce the inhibition. Additionally, 
published work focuses on DARQ LAMP implemented in assays with high 
magnesium content. Because LAMP assay conditions are highly dependent on 
the primer set, a more comprehensive understanding of the impacts of DARQ 
LAMP on reaction efficiency is necessary. Furthermore, the advent of Bst 3.0 
DNA Polymerase, which has increased processivity, offers the opportunity to 
rescue the delayed amplification times of DARQ LAMP, but doing so requires 
in-depth optimization. 
In this study, we investigate for the first time the use of these newer 
strand-displacing polymerases in LAMP with four- and six- primer systems.  We 
show that DARQ LAMP in previously reported conditions can only operate with 
high magnesium content, and thus completely inhibit LAMP assays where 
primer designs require lower magnesium.  However, we demonstrate that 
Bst 3.0 can rescue the amplification for a broader range of assay conditions. 





amplify three genes from the MRSA genome within a single sample.  Though 
the triplex assay had lower amplification performance than optimized singleplex 
assays, we were able to detect with times-to-positive of less than 30 minutes.  
The results of this study demonstrate the optimal conditions for a triplex LAMP 
assay for MRSA detection (a pathogen that requires detection of three genes 
for confirmation), while also informing the community on approaches for the 
broader use of DARQ LAMP for multiplexed LAMP. 
4.2 Materials and Methods 
4.2.1 Preparation of DNA standards 
Genomic DNA from methicillin-resistant Staphyloccus aureus (MRSA, 
strain USA300_TCH1516, NC_010079.1) was purchased from American Type 
Cell Culture (ATCC). Lyophilized DNA was resuspended in a 50% glycerol 
stock at 107 copies/µL, and its concentration was verified by measuring the 
OD260 with the NanoDrop ND-3000 (ThermoFisher Scientific). The genomic 
DNA was then aliquoted to 50 µL volumes and stored at -20 °C. Ten-fold 
dilutions of the stock DNA were prepared in water for all experiments. 
4.2.2 LAMP Primer Design 
Targets amplified and quantified in this study are genes associated with the 
resistance and virulence factors present in the MRSA genome. Genes 
encoding for femB (Genbank: ABX29322.1) and mecA (Genbank: 
ABX28076.1) were chosen as resistant-specific genes, and spa (Genbank: 





system targeting femB was described previously200 and the mecA, spa, and 
femB-2 primer systems were designed using the PrimerExplorer_v5 software 
(http://primerexplorer.jp/e/, Eiken Chemical Co., Ltd.). All DNA oligonucleotides 
(listed in Table 4.1) were purchased through Integrated DNA Technologies 
(IDT). 100 µM working stocks were prepared in 1x Tris-EDTA buffer (provided 
through IDT) and stored at -20 ⁰C. 
Table 4.1. LAMP primer and probe sequences. * denotes that the 5’ end of the sequence was 
labeled with an Iowa Black FQ or RQ quencher. All probes have the designated fluorophore 
labeled at the 3’ end. 
Targeted 























4.2.3 Amplification time dependence on primer number or engineered 
polymerases 
To investigate the impact of increasing primer number on Time to 
Positive (TTPs), two primer sets were designed specific to the femB gene. The 
first primer set, femB (Table 4.1), only allowed for design of one loop primer 
given the constraints of the PrimerExplorer software. The second femB primer 
set (femB-2) was redesigned as an AT-rich genome to facilitate design of both 
a forward and backward loop primer. These experiments did not include the 
quencher probe duplex. Instead, unlabeled primers were used, with an 
intercalator as the fluorescent readout. 
For these experiments, 20 µL reaction volumes were prepared where 
the primer concentrations were kept constant: 0.2 µM of F and B outer primers 
(F3 and B3), 0.8 µM of loop primers (LoopF and LoopB), and 1.6 µM of F and 
B inner primers (FIP and BIP). Experiments using Bst Large Fragment (Bst LF, 
New England Biolabs) consisted of 1x ThermoPol buffer (New England 
B3 TGATGCTAAAGTTCAAAAGAGT 











Biolabs) supplemented with 0.6 M betaine (Sigma-Aldrich), 8 mM MgSO4 (New 
England Biolabs), 1.4 mM dNTPs (New England Biolabs), 1 µM SYTO-82 
(ThermoFisher Scientific), and 0.32 U/µL of Bst LF. Reactions were then 
heated to 61 °C for 60 minutes followed by a 2-minute heat kill step at 80 °C 
using a thermocycler (LightCycler 480 System II). Reaction conditions for 
Bst 2.0 consisted of 1x Isothermal Amplification Buffer I (New England Biolabs), 
0.2 M betaine, 0.64 mM dNTPs, 1 µM SYTO 82, and 0.32 U/µL of Bst 2.0 (New 
England Biolabs). These reactions followed the same heating protocol as 
Bst LF. Lastly, Bst 3.0 had the same conditions as Bst 2.0 except that 1x 
Isothermal Amplification Buffer II (New England Biolabs) was used, and 1 mM 
MgSO4 was supplemented into the reaction. Bst 3.0 (New England Biolabs) 
was added to those reactions at the same concentration used for Bst LF and 
Bst 2.0. Reactions containing Bst 3.0 were heated at 65 °C for 60 minutes 
where fluorescent readings were taken every 30 seconds. This incubation was 
followed by a 2-minute 80 °C heat kill step.  
4.2.4 Titration of quencher probe duplex into LAMP reactions 
As noted by Tanner, et al.,201 some amount of unlabeled inner primer 
must be present in the reaction to prevent full inhibition of amplification. The 
original paper used a 1:1 ratio, where one half was the unlabeled inner primer, 
and the other have was the quenched inner primer and the labeled probed 
(quencher probe duplex, QPD). Initial experiments at this ratio inhibited all 
amplification; thus, we conducted a titration of the QPD, with the mecA primer 





and labeled probe were hybridized by incubating the sequences at 5 µM at 
95 °C for two minutes, and slow cooled to room temperature using a heat block. 
DARQ LAMP assays using Bst 2.0 (at the conditions describe above with 105 
copies of MRSA genomes) were then performed using the denoted 
percentages in relation to the total amount of unlabeled forward inner primer. 
Similarly, DARQ LAMP reactions for Bst 3.0 were also performed at the 
conditions described above. For both enzymes, EvaGreen (Biotium) was 
included in the reactions to confirm amplification had occurred. 
4.2.5 DARQ LAMP reactions 
Once the optimal amount of QPD was determined from the titration 
experiments, 10% QPD were incorporated into all LAMP reactions using 
Bst 3.0. Inner primers labeled with asterisks in Table 1 were reduced to 1.44 
µM for these reactions to maintain a 10% ratio of QPD to unlabeled inner 
primer. All reactions conditions for Bst 3.0 outlined previously were applied to 
these experiments, without including intercalator. Fluorescent readings were 
taken every 30 seconds during a 65 °C incubation, followed by a 2-minute 
heat-kill step at 80 °C. Signals were normalized to maximum fluorescence to 
account for differences in quantum yield. 
4.2.6 Melt curves for quencher probe duplexes 
To assess the melt temperature of the hybridized probe and quenched 
inner primer, reactions consisting of 1x Isothermal Amplification Buffer II, 0.2 M 





were prepared. Primers and SYTO 82 were not included as they minimally 
impact hybridization of the QPD. Reactions then underwent a melt protocol 
where the temperature was raised from 55 °C to 95 °C at 0.2 °C increments, 
and were read at each increment using the LightCycler. Melt temperatures 
were calculated by plotting the derivative of each melt curve and taking the 
minimum value from the data set. 
4.2.7 Calculation of time-to-positive 
Given that the thermocycler’s included software calculates cycle 
threshold, the software-provided analysis is not as accurate for LAMP. Using 
the raw data collected from the thermocycler, data was plotted against time, 
and the amplification curves were then fitted to a modified generalized logistic 
curve: 
      (Eq. 4.1) 
Here, Fmax is the fluorescence at infinite time, or at saturation, F0 is the baseline 
fluorescence (at t ≈ 0), b is the growth rate, and thalf is the time at which the 
fluorescence is at half maximum. Using the same methodology presented by 
Subramanian and Gomez,202 the TTP can then be calculated with Equation 2. 
All curve fits had a coefficient of determination R2 > 0.95 before TTPs were 
calculated using the fitted constants. 
      (Eq. 4.2) 












4.3 Results and Discussion 
4.3.1 Higher generations of strand-displacing polymerases provide 
faster assay times 
While the elimination of thermal cycling contributes to a reduction in 
assay time as compared to PCR, another significant reason for the increased 
speed of product generation is the processivity of the strand-displacing 
polymerase, New England Biolabs (NEB) has developed three 
strand-displacing polymerases that have been consistently used in LAMP 
assays. The original enzyme employed in LAMP is Bst DNA Polymerase, Large 
Fragment (Bst LF). With this enzyme, there were reports where times to 
positive were shown to be as low as 20 minutes.203 However, given that each 
LAMP assay must be optimized for each designed primer set, amplification 
times can vary widely for different assays, and TTPs can be as high as 45 
minutes, even for high template concentrations (Figure 4.2A). As a result, 
quicker and more robust Bst polymerases have been introduced. NEB’s Bst 2.0 
DNA polymerase (Bst 2.0) was developed not only to achieve faster 
amplification times, but also to show enhanced activity extending off of RNA 
targets, thus eliminating the need for an additional reverse transcription step. 
The next iteration, Bst 3.0 DNA polymerase (Bst 3.0), further builds upon these 
improvements, providing faster amplifications times and robustness against 
inhibitors as compared to Bst 2.0. With both of these enzymes, we have 
observed that amplification times can be achieved in less than 30 minutes with 





Bst 3.0 are 10 minutes faster than those with Bst 2.0 (Figure 4.2B). As a result, 
the majority of LAMP publications have moved away from using Bst LF, and 
now primarily use Bst 2.0 or Bst 3.0. 
 
4.3.2 Increased primer number enables 15 minute assay times with 
higher generation polymerases 
An additional reason for reduced assay times is the number of primers 
present in the assay. The incorporation of four core primers allows for 
increased assay times due to their consistent extension when hybridized to the 
template, as well as the multitude of downstream amplicons. Since the original 
publication, Notomi, et al., developed another method to decrease assay times 
with the incorporation of two loop primers that participate downstream of the 
initial reaction.204 Briefly, the starting material produced by LAMP is a 
dumbbell-like structure, and as inner primers continue to hybridize and extend 
Figure 4.2. Amplification time dependence upon different strand-displacing enzymes and 
upon the number of primers. (A) Averaged traces (n = 3) of 105 copies of MRSA genome 
using three different strand-displacing enzymes. Reactions run with the latest iteration of Bst 
DNA polymerase, Bst 3.0, show faster amplification times as compared with Bst polymerase 
used in the original LAMP publication, Bst DNA polymerase Large Fragment (Bst LF). (B) 
Amplification of reactions in A show Bst 3.0 has time to positives (TTPs) of roughly 20 
minutes, 10-25 minutes faster than Bst 2.0 and Bst LF respectively.  Error bars represent 
the standard deviation across n = 3. (C) Incorporation of loop primers into LAMP reactions 






of this dumbbell structure, more complex structures consisting of multiple loops 
are generated. The loop primers hybridize to these secondary loop structures, 
where inner primers do not anneal, and provide more extension sites to further 
produce exponential signal generation. From the two loop primers for the 
femB-2 set, amplification times were observed to be 15 minutes less than an 
assay run with only the core primers (Figure 4.2C). Additionally, the increased 
extension sites that loop primers offer can provide increased sensitivity.  
While these advantages are very attractive for any assay, it is important 
to note that the design of a six-primer system is not straightforward. Once the 
core primers have been designed, those primers are input into the software 
again to design the loop primers. Loop primers will not be designed if there is 
limited space between the F2 and F1c regions (or B2 and B1c) or the sequence 
does not have the required GC content to sustain the necessary melt 
temperatures. In addition, each primer set must be validated, and often times 
several primer sets must be designed given the complexity. Because of these 
limitations, designing a six-primer system is often challenging, and, in some 
cases, is not possible.  
4.3.3 Bst 3.0 shows more robustness against QPD’s inhibitory effects 
Previous DARQ LAMP publications suggest using a 1:1 ratio of QPD to 
unlabeled inner primer, as the unlabeled primer prevents the reaction from 
being completely inhibited. However with both Bst 2.0 and Bst 3.0 in reactions 





not shown). We conclude that this occurs because the LAMP assays have been 
optimized with 8 mM magnesium (Mg2+), a common concentration for most 
LAMP assays.201 This is problematic as the Mg2+ content for varying primer sets 
ranges from 2 mM to 10 mM, and therefore this 1:1 ratio cannot be universally 
applied to all assays. Because the primer sets in this study require a much 
lower Mg2+ concentration of 3 mM, we can assume that the optimal ratio of 
QPD to unlabeled inner primer is much lower for these assays.  
 
After confirmation that the QPD’s melt temperatures were above the 
operating assay temperature (Figure 4.3), the optimal amount of QPD was 
determined by titrating QPD in LAMP reactions containing either Bst 2.0 or Bst 
3.0 to better discern the inhibitory effects’ impact on both enzymes (Figure 4.4). 
With Bst 2.0, we observe that with lower titrations of QPD, we see no drastic 
impact on TTPs when compared to reactions with intercalator and no QPD 
present. However, once we surpass 15% QPD (i.e. 85:15 unlabeled primer to 
QPD), the TTPs are drastically longer compared to reactions with only 10-15% 
QPD. In comparison to a primer set optimized for 8 mM Mg2+, the TTP 
Figure 4.3. Melt curves for QPDs across all primer sets. (A) femB melts show a melt 





difference between 10% and 25% QPD is roughly 3 minutes;199 this suggests 
that for LAMP reactions that operate at low concentrations of Mg2+, Bst 2.0 has 
a very narrow range in which DARQ LAMP remains a robust method for 
detection. In contrast, QPD present in reactions containing Bst 3.0 has a lesser 
impact on enzyme inhibition. As with Bst 2.0, we observe similar TTPs with 
10% QPD when compared to the intercalator-only control. As the amount of 
QPD increases, we observe a gradual increase in amplification times, however 
it is not as aggravated as those observed with Bst 2.0.  
To further investigate the inhibitory effects on both enzymes, EvaGreen 
was added to reactions containing QPD to determine whether overall DNA 
generation was delayed, and more readily observe the kinetic changes 
occurring the reaction. Overall, the reactions that were supplemented with 
intercalator showed delayed TTPs that agreed with those that measured the 
fluorescence from the QPD (Figure 4.5). Reactions with Bst 2.0 showed a delay 
Figure 4.4. Comparison of amplification times with increased QPD concentrations using Bst 
2.0 and Bst 3.0 in LAMP reactions. ∆TTPs compare the TTP from the QPD reaction with a 
LAMP reaction that consists of intercalator only over n = 3. At QPD concentrations higher 
than 10%, we observe significant amplification delays, suggesting that the polymerase is 
being inhibited at these concentrations. Overall Bst 2.0 shows amplification times that are 
harshly aggravated with increasing QPD as compared to Bst 3.0, suggesting that the latter 
enzyme is more robust against the inhibitory effects of QPD. Error bars represent standard 





in time to positive without any changes to the amplification efficiency, as shown 
by the minimal change in slope across QPD amounts (Figure 4.5A).  
Interestingly, while reactions with Bst 3.0 show slight changes in TTPs, we 
observe decreasing slopes in the amplification curves as we increase the 
amount of QPD. This seems to suggest that the presence of QPD does inhibit 
both enzymes, however the mechanisms of inhibition are different. The 
differences observed between Bst 2.0 and Bst 3.0 are most likely due to design 
changes made during the directed evolution of the enzyme and therefore, may 
only be alleviated with changes to assay conditions that further promote 
polymerase activity such as adding DMSO.205  
Figure 4.5. Amplification traces from either intercalator or probe in QPD doping reactions. 
Reactions with either Bst 2.0 or Bst 3.0 were supplemented with intercalator (A and B). 
Intercalator signals confirm that the presence of QPD delays amplification times that agreed 





4.3.4 DARQ LAMP enables singleplex and multiplex detection of MRSA 
genomes across all three genes 
The original DARQ LAMP publication had demonstrated its multiplexing 
capabilities by assaying different genomes within a single reaction. For 
applications that require the identification of different genes present within a 
single genome, it remains unclear how the increasing amount of primers and 
QPDs impacts the efficiency of DARQ LAMP. One example of such an 
application is the identification of MRSA, where PCR tests have become a gold 
standard diagnostic.10 To investigate this, three primer sets that identify S. 
aureus and genes that encode its methicillin resistance were designed and 
validated. Two resistance genes, mecA and femB, are often tested as they 
encode methicillin resistance and the virulence of this resistance,206 
respectively, whereas spa is a known virulence factor207 associated with 
S. aureus specifically. LAMP reactions were first optimized for the femB primer 
set and were then applied to reactions with mecA and spa primer sets. Using 
an intercalator for single gene detection and purified MRSA genomic DNA 
(MRSA gDNA), the limit of detection for all three primer sets was 102 – 103 
copies per reaction (Figure 4.6). Given the results shown in Figure 4.3, 10% 
QPD was chosen to minimize the delay in TTP while maintaining high 
discrimination between baseline and signal amplitude. Using DARQ LAMP for 
singleplex detection, we observe that for the femB and spa primer sets, we can 
detect 103 copies within 30 minutes (Figure 4.7). However, for the mecA primer 





reaction conditions were optimized for femB using an intercalator to assess 
fluorescence, it is apparent that these conditions are suboptimal for DARQ 
LAMP reactions.  
Duplex detection of MRSA gDNA was investigated by using the femB 
and spa primer sets. Looking at the individual primer sets following 
Figure 4.7. Singleplex detection of femB (A), mecA (B), and spa (C). All amplification 
reactions used 160 nM of QPD in the LAMP reactions. Amplification traces are averaged 
over n = 3. (D) plots the TTPs for all primer sets across copy number, where error bars 
represent standard deviation. 
Figure 4.6. Genome dilutions with 1 µM SYTO 82 (intercalator) to assess limits of 
detection across all three primer sets. (A) femB shows high discrimination between 
concentrations of 103 copies and higher, and 100 copies and lower. (B) mecA show 
amplification of 103 copies and higher, with no amplification at lower concentrations. (C) 





amplification, we observe that while the spa primer set maintains strong 
amplification curves (Figure 4.8B) without significant changes to TTP (Figure 
4.8F), detection from the femB primer set shows detection of 105 and 104 
copies only (Figure 4.8A), suggesting that the reaction conditions for this primer 
set become less favorable with the increased number of primers and QPDs 
present in the reaction. This applies to triplex detection that includes all three 
primer sets (Figure 4.8D), where 104 copies detected with the femB primer set 
amplifies 10 minutes later when compared to TTPs from duplex detection 
(Figure 4.8F). It appears that the reaction efficiency with the femB primer set 
worsens with additional primer sets, as well. Interestingly, mecA and spa primer 
sets show similar delays (approximately 5 minutes) in TTPs for triplex detection 
in comparison to singleplex detection.  
Figure 4.8. Duplex and triplex detection of MRSA genes. Duplex detection of MRSA 
measured fluorescence of QPDs for the femB (A) and spa (B) primer sets, where TTPs were 
calculated and plotted in (C). Triplex detection was evaluated using 104 copies of MRSA with 
all three primer sets (D). TTPs were plotted (E) and TTPs for spa and femB primer sets were 
compared to those from singleplex detection with QPD to assess the impact of increased 
primer sets present in the reaction (F). All amplification traces are averaged over n = 3, with 






Here we have designed and demonstrated a LAMP assay that 
simultaneously detects three MRSA genes within a single sample.  To enable 
multiplexing, we have utilized the DARQ LAMP paradigm, which we believe to 
be the most robust and universal approach for multiplexing with LAMP.  
However, unlike Taqman PCR, DARQ LAMP is highly sensitive to reaction 
conditions and thus requires additional study to be broadly applied.  
Specifically, we have shown that DARQ LAMP is best suited for assays 
that require a high Mg2+ concentration. This provides greater stability for the 
QPD and provides a greater working range of %QPD when using Bst 2.0. In 
fact, a narrow range of 10-15% QPD shows similar TTPs to intercalator-only 
controls when using Bst 2.0 and moderate Mg2+ concentration.  Given the 
emergence of Bst 3.0, we studied its use in DARQ LAMP for the first time. We 
investigated the optimal quencher-probe duplex fraction in the assay for both 
Bst 2.0 and Bst 3.0 and (i) we determined the optimal ratio, and (ii) we 
demonstrated that Bst 3.0 is more tolerant to the QPD doping required for 
DARQ LAMP.  We then further optimized the DARQ LAMP assay for triplex 
detection of MRSA genes. While the performance of DARQ LAMP is hindered 
when optimizing for three gene targets simultaneously, we were ultimately able 
to achieve detection of all three MRSA genes in a single sample with a TTP 





Chapter 5. Transcription Cycling Amplification: a novel isothermal 
amplification scheme for the direct detection of microRNA 
 
5.1 Introduction 
Within the last decade, miRNA have become a focus in biomarker 
discovery and subsequently disease diagnostics. These nucleic acids are a 
subclass of noncoding RNAs that are roughly 22 nucleotides in length,208 and 
are largely known to regulate the translation of mRNAs by promoting mRNA 
degradation or inhibiting protein translation.209 As a result, miRNAs play a large 
role in various cell processes, such as proliferation,210–212 differentiation,213–215 
and cell death.216,217 Because each class of miRNA has a characteristic 
expression profile, they hold promise as diagnostic biomarkers for tissue-
specific or stage-specific diseases. Additionally, miRNA targets have been 
reported to circulate either freely in bodily fluids218,219 or within exosomes,220,221 
suggesting great potential towards the development of a liquid biopsy for 
minimally-invasive diagnostic techniques. 
Early miRNA detection techniques were variations of hybridization 
assays, the most popular of these techniques being the Northern Blot. Similar 
to the Southern blot, Northern blots rely on electrophoresis for band 
identification, transfer onto a nitrocellulose membrane, and labeling with 
fluorescent or radiolabeled complementary probes. This method can take over 





expertise involved, it also does not facilitate high throughput analyses. As 
traditional hybridization assays evolved into DNA microarrays to address the 
need for high throughput analyses, these were quickly adopted towards the 
detection of various miRNA targets. With the conjugation of various 
complementary probes, these platforms enable the screening of a large 
number of miRNA that cannot be achieved with traditional hybridization assays. 
Detection with DNA microarrays requires multiple steps, starting with the 
isolation of miRNA targets, which are converted to complementary DNA 
(cDNA) with use of reverse transcriptase (RT). These cDNA sequences are 
then labeled and added to a microarray for hybridization. As a result, detection 
with this method involves various procedures beforehand that not only require 
technical expertise, but lengthen the amount of time required to run the assay. 
With the advent of PCR and its derivative for RNA targets, RT-PCR, this 
amplification-based detection scheme has become the gold standard for 
miRNA expression quantification, and is often used to confirmed results 
obtained for microarray profiling.223 However, miRNA have presented a very 
unique problem for traditional RT-PCR methods: first, miRNA are roughly the 
same size as primers used for both cDNA synthesis and PCR; second, they do 
not have the poly-A tail that is normally leveraged for cDNA synthesis of mRNA. 
The most popular alternative method specific for miRNA targets involves the 
use of a stem-loop primer. This method requires the design of a hairpin primer 
where the 3’ arm is elongated compared to the 5’ arm. The longer arm can then 





against the miRNA target and further elongate the 3’ arm. As a result of primer 
elongation, the complementary sequence is embedded into the product, thus 
creating a longer template that is better suited for PCR. However, traditional 
RT protocols for RNA targets involve converting all RNA targets in a sample to 
cDNA, and therefore the specific detection of RNA is still heavily reliant on PCR 
with the use of target-specific primers. While it would be ideal to perform PCR 
directly by assaying the RNA targets themselves, RNA is highly sensitive to 
temperature, where temperatures above 65 °C begin to degrade RNA targets. 
Therefore, this RT step is crucial for any PCR-based method for RNA 
quantification. 
To address the need for direct RNA detection to shorten assay times, 
several isothermal amplification schemes have been developed to operate in 
temperature ranges better suited for RNA targets. The two most popular 
methods are nucleic acid sequence-based amplification (NASBA)125 and 
exponential amplification reaction (EXPAR),224 where both assays create 
analogs of the target sequence to enable positive feedback into the reaction, 
thus facilitating exponential amplification. However, NASBA (described in 
section 2.3.2.2.4) is better suited for longer RNA targets, such as mRNA.225 As 
a result, EXPAR (described in section 2.3.2.2.2) is one of the few amplification 
schemes that enables direct detection of miRNA226 by leveraging both a DNA 
polymerase and a nicking enzyme, along with a symmetric template. However, 
for low copy number detection, EXPAR often suffers from nonspecific 





further exacerbated by the presence of the nicking enzyme,114 or nonspecific 
hybridization of templates and molecular beacons for multiplex detection.227  
Here, we aim to create a novel amplification scheme that leverages 
elements from both EXPAR and NASBA. Like EXPAR, we leverage a 
symmetric template where the generated analogs of miRNA targets feed back 
into the system to enable rapid, exponential signal generation. Instead of 
flanking a nicking enzyme recognition sequence like in EXPAR, the symmetric 
template instead flanks the anti-sense recognition sequence of an RNA 
polymerase and a user-designed sequence for easy integration of a labeled 
probe (Figure 5.1A). By leveraging the sequence recognition of RNA 
polymerases to initiate RNA generation, a RNA transcript is generated that 
hybridizes to the target binding region, resulting in amplification through this 
cyclic transcription process (Figure 5.1B); thus we have named this 
approached Transcription Cycling Amplification (TCA).  
In this endeavor, there are several questions that need to be answered 
towards the design of a multi-enzyme isothermal amplification system. 
Specifically, we aim to study the following: (i) assessing the impact of various 
DNA and RNA polymerases, (ii) evaluating template designs to limit 
nonspecific interactions, and lastly (iii) optimizing buffer conditions to achieve 
rapid, specific amplification and detection. Each of these studies will provide 
information regarding nucleic acid and enzyme interactions, and inform key 





the investigation of these three areas, we aim to achieve a direct amplification 
method specifically for microRNA that enables rapid quantification.  
 
Figure 5.1. Transcription Cycling Amplification (TCA). (A) The starting material in TCA 
centers around a prehybridized duplex, consisting of a template with 5’ quencher and a probe 
with a 3’ fluorophore. The template consists of two regions that are complementary to the 
target of interest. These two regions flank the anti-sense sequence of an RNA polymerase 
promoter and a user-designed sequence. This user-designed sequence is then leveraged to 
design probes that are specific to the target of interest, and therefore its complementary 
target. Additionally, because the probe partially overlaps the right half of the template, this 
enables the target to preferentially bind to the left side of the template to begin TCA. (B) TCA 
begins upon binding of the miRNA target to the left half of the template. A DNA polymerase 
(blue) then recognizes the target’s 3’ end to begin extension. (a) Extension of the target 
forms the double-stranded promoter region, and either displacement (as drawn) or 
degradation of the probe. Separation of the probe from the template leads to unquenched 
fluorescence that can be monitored in real-time. (b) With the creation of the double-stranded 
promoter, the RNA polymerase (green) recognizes the synthesized sense sequence to 
transcribe everything downstream. As the template is symmetric, the RNA transcripts are 
analogous to the miRNA targets. (c) These RNA transcripts can then bind to another 
prehybridized probe-template duplex and continue the same extension (d), transcription (e), 






5.2 Materials and Methods  
5.2.1 Synthetic oligonucleotide design and preparation 
Let7a, a common miRNA target for cancer expression profiles, was 
chosen as the target of interest for the work presented here. Templates consist 
of the reverse complement of the let7a target on both the 3’ and 5’ ends (Figure 
5.2); however, to favor target binding and extension along the template, the 
reverse complement on the 5’ end only contains the last 15 of the 22 
nucleotides. To further increase the probability of the target binding to the full 
complement, a user-designed sequence, different for each assayed target, 
follows the 13-nucleotide complement. This enables a probe to hybridize at this 
site and to cover a small portion of the miRNA complement, and therefore act 
as interfering or blocking DNA to further bias the miRNA binding to the 3’ end. 
The designed probes should have a melt temperature of at least 45 °C to 
ensure stable binding of the probe and template during the reaction, and 
secondary structures should be verified to ensure that probes do not bind to 
any other region of the template. Lastly, the reverse complement of the RNA 
Figure 5.2. Sequence design for TCA templates. The reverse complement of the intended 
target is present on both the 3’ and 5’ ends of the target. However the sequence on the 3’ 
contains the full complement to bias hybridization to the 3’ end. These two reverse 
complements flank the anti-sense recognition sequence of the RNA polymerase, and a 






polymerase recognition sequence, known as the promoter, is incorporated 
between the full complement and the user-designed sequence.  
Secondary structures of all template and probe designs were assessed 
using the web-based software, NuPack. Often, secondary structures arise at 
the promoter region, or between the designed probe region and the reverse 
complement. Here, the designed probe can be elongated as necessary to 
minimize secondary structure, however the probe (including the 
complementary target region) should not be less than 15 nucleotides, should 
not contain the full complement of the target, and should have at least 50% 
GC-content to ensure stable binding onto the template. All nucleotides were 
purchased through Integrated DNA Technologies (IDT). Table 5.1 lists all the 
sequences used in this work. All templates were ordered with HPLC 
purification, and with a 3’ phosphate group to prevent extension. 
Table 5.1. Oligonucleotide sequences for TCA. 
Oligonucleotide Sequence (5’  3’) 
Sequences with T7 RNA polymerase promoter 
Target* TTT TTT TTT TGA GGT AGT AGG TTG TAT AGT T 
Template 
AAC TAT ACA ACC TGA CTG CAT GCT ATA GTG 
AGT CGT ATT AAA CTA TAC AAC CTA CTA CCT 
CA 
Probea CAT GCA GTC* AGG TTG TAT AGT T 
Sequences with T7 RNA polymerase promoter for displacement 
Templateb 
AAC TAT ACA ACC TGA CTG CAT GCT ATA GTG 
AGT CGT ATT AAA CTA TAC AAC CTA CTA CCT 
CA 





Sequences comparing SP6 and T7 RNA polymerase activitiesd 
SP6 template GAT ACA ACC TCA TGG CTC TTC TAT AGT GTC ACC TAA AT 
SP6 probee AAG AGC CAT GAG GTT GTA TC 
SP6 promoter ATT TAG GTG ACA CTA TAG 
T7 probee CAT GCA GTC AGG TTG TAT AGT T 
T7 promoter TAA TAC GAC TCA CTA TAG 
SP6 templates with various sequence configurations 
let7a SP6 templateb,f 
(probe after 
promoter) 
AAC TAT ACA ACC TGA CTG CAT GCT ATA GTG 





AAC TAT ACA ACC TAC TAT AGT GTC ACC TAA 
ATG GGC TTC TAT TCT ACT TCA ACC TAA CTA 
TAC AAC CTA CTA CCT C 
Probe for template2e GAA GTA GAA TAG AAG C 
SP6 hairpin template 
AAC TAT ACA ACC TAC GCT GCT ATA GTG TCA 
CCT AAA TGC AGC GTA GGT TGT ATA GTT AAT 
GGA ACT ATA CAA CCT ACT ACC TC 
(a) FRET probe labeled with a 5' fluorophore, and 3' quencher. The asterisk denotes the 
location of an internal quencher (b) Oligonucleotide labeled with a 5' quencher (c) 
Oligonucleotide modified with a 3' fluorophore (d) T7 templates used for these experiments are 
uses the unlabeled template under “Seqences with T7 RNA Polymerase promoter” 
(e) Oligonucleotide modified with a 3’ phosphate group (f) Template uses the same probe used 
for T7 displacement experiments. *Target includes a 5’ poly-T tail to differentiate target 
extended by DNA polymerase from the template in gel analyses for assay characterization. 
FRET probes and unlabeled templates, or labeled probes and quenched 
templates are prehybridized at 2 µM in nuclease-free water (NEB), where 
sequences are incubated at 95 °C for two minutes on a heat block and left to 
cool until the temperature reaches room temperature. 
5.2.2 TCA reactions 
TCA reactions were conducted in buffer conditions that favor RNA 





consisted of 1× optimized transcription buffer (Promega, consisting of 10 mM 
Tris-HCl, 6 mM MgCl2, 10 mM NaCl and 1 mM spermidine), 10 mM DTT 
(Promega), 500 µM dNTPs (NEB), 500 µM NTPs (NEB), 20 U of human 
placenta-derived RNase inhibitor (NEB), nuclease-free water, and 200 nM 
prehybridized probe-template duplex in 20 µL reactions, unless otherwise 
noted. The impact of various buffer components such as NaCl (JT Baker) and 
KCl (JT Baker) were investigated with relevant concentration information 
included in the figure captions. For experiments where various DNA 
polymerases were tested, 1 U of the designated DNA polymerase was used for 
each reaction. All DNA polymerases were purchased from NEB. The RNA 
polymerases in this study, T7 and SP6 RNA Polymerases, were purchased 
from Promega. 10 U of T7 RNA polymerase or 10 U of SP6 RNA polymerase 
were used for each reaction, unless otherwise noted. All assays were incubated 
at 37 °C for 30 – 60 minutes, followed by a 2-minute 80 °C enzyme-kill step. 
Reactions incubated at 42 °C are noted in the figure captions. 
5.2.3 Real-time fluorescent measurements 
All fluorescence values reported here were measured using a BioRad 
MJ MiniOpticon thermocycler, with software supplied by the manufacturer. The 
real-time measurements on this instrument were made using an isothermal 







5.2.4 Product verification with gel electrophoresis 
All amplification products were run on a 15% denaturing gel (29:1 
acrylamide:bis-acrylamide), with 8 M urea (Sigma Aldrich). Samples were 
denatured in a 1x RNA loading buffer consisting of 47.5% formamide (Sigma 
Aldrich) and 0.5 mM EDTA (Sigma Aldrich). Gels were run for 20 minutes at 
500 V in 0.5x TBE buffer, and were then stained using 0.5x SYBR Gold. 
Experiments that assessed nonspecific degradation with labeled probes were 
imaged first without staining under UV excitation, and were then stained with 
0.5x SYBR gold. 
5.3 Results and Discussion 
5.3.1 The impact of various polymerases on TCA  
Overall, the crux of this assay is the sequence-dependent initiation of 
RNA polymerase to produce target analogs. To achieve this goal, the first study 
aims to determine which DNA polymerase enables robust extension to produce 
the double-stranded promoter region. Because the assay conditions favor the 
activity of the RNA polymerase, the DNA polymerase must be able to extend 
the target efficiently in these sub-optimal conditions. Additionally, the extension 
of the target must enable probe degradation or displacement such that 
real-time fluorescent signals are robust enough to differentiate positive and 
negative samples. This section evaluates several different DNA polymerases 





5.3.1.1 Investigating the impact of DNA polymerases with 
exonuclease activities 
When considering which of the abundant DNA polymerases to use for 
this assay, we first investigated the impact of both 5’  3’ and 3’  5’ 
exonuclease domains. The 5’  3’ domain is known as the nuclease portion of 
the enzyme, and is primarily used in Taqman PCR applications. Here, as the 
the Taq polymerase extends the primer, the 5’  3’ domain is responsible for 
the degradation of the Taqman probe downstream for signal generation. The 
3’  5’ exonuclease domain is responsible for proof-reading activity, and is 
primarily responsible for excising mismatched nucleotides during the 
polymerization process. It has been previously suggested that the activity of 
these 2 – 3 domains (including the polymerase domain) involves competition 
between the active sites as a primer is shuttled between them.228 Therefore, it 
is crucial to evaluate how the presence of these exonuclease domains interact 
with both the target and the probe, and subsequently, impact target extension 
and probe degradation or displacement. 
5.3.1.1.1 Bst DNA  Polymerase, Full Length 
Our first design of TCA used a linear template, with a prehybridized 
FRET probe with a 5’ label and 3’ quencher, instead of a quenched template 
and labeled probe as drawn in Figure 5.1A. By isolating the FRET signal to a 
single sequence, it was assumed that this would greatly simplify the system. 





DNA extension, Bst DNA polymerase, Full Length (Bst Full) was chosen for two 
main reasons. First, it is a DNA polymerase that also has 5’ to 3’ exonuclease 
activity, similar to Taq Polymerase. This would enable the degradation of any 
nucleic acid it encounters as it is extending the target sequence, and can 
facilitate probe degradation for signal generation. Second, this DNA 
polymerase recognizes both DNA and RNA primers. This is especially 
important because in order to achieve both the linear amplification via the 
extension of the miRNA target, and exponential feedback using the 
downstream RNA transcripts, the DNA polymerase must be able to extend an 
RNA sequence. For the RNA polymerase, T7 RNA polymerase (T7) was 
chosen, as it is a widely-used polymerase for cloning and RNA synthesis 
applications given its strong promoter activity.229–231 Because TCA is heavily 
reliant on the generation of RNA for feedback, having an RNA polymerase that 
robustly transcribes a template is essential. 
Using these two enzymes with this initial design, we first demonstrated 
in a piece-wise fashion the feasibility of TCA. In Figure 5.3A, we confirm that 
linear amplification and the generation of target analogs occur as we expect. In 
lanes 1 and 2, Bst Full is added to a reaction with target and template, and we 
observe in lane 2 the disappearance of the target band (roughly 30 nucleotides 
in length) from lane 1 and the emergence of a band longer than the template. 
This demonstrates we have efficient and complete conversion with Bst Full. 
Lanes 3 and 4 assess the exonuclease activity of Bst Full by including the probe 





incomplete conversion of the target, seen by the faint target band still present 
in comparison to lane 3, and incomplete conversion of the probe, suggesting 
that when both polymerase and exonuclease functions are engaged, this 
enzyme loses some efficiency in comparison to having polymerase activity 
alone. Lastly we verify that the synthesis of a double-stranded promoter leads 
to the generation of RNA. By including T7 in the reaction (lane 5), we observe 
a new band that is present beneath target band that matches the expected 
length of the RNA transcripts. RNA transcripts were confirmed with a post—
amplification treatment of DNase I to remove the probe, templates, and targets 
from the reaction (data not shown). This isolated DNA was then used to confirm 
that the exponential feedback occurs as expected. Reactions consisting of 
isolated RNA, template alone, and Bst Full demonstrated that RNA can be 
extended (lane 6), and with the addition of RNA polymerase, the 
Figure 5.3. Piecewise demonstration of TCA. (A) Lanes 1 and 2 verify that the target is 
extended when bound to the template. Lanes 3 – 5 confirm that alongside Bst Full's 
polymerase activity, the exonuclease activity leads to the degradation of the probe. Addition 
of the RNA polymerase leads to transcription due to the presence of the double-stranded 
promoter. Lanes 6 and 7 confirm positive feedback where isolated RNA is extended along 
the template in the presence of the Bst Full, and alongside the T7, it will further propagate 
transcription that is observed in the initial linear amplification phase. (B) Real-time signals of 





double-stranded promoter will lead to transcription (lane 7), increasing the 
potential for positive feedback in the reaction. 
Thus far, we have demonstrated that upon binding to the template, a 
target can be extended by Bst Full, leading to probe degradation and formation 
of the double-stranded promoter. Only in the presence of this double-stranded 
promoter does the RNA polymerase begin transcription, where the generated 
RNA can bind to template to repeat the steps of extension and probe 
degradation. However, when we assess the full system with two different target 
concentrations and a no target control (NTC), the result does not distinguish 
the two concentrations, and more concerning, there is a signal in the absence 
of target (Figure 5.3B). The only way for signal generation to occur with a dual-
labeled probe is if the fluorophore was separated from the oligonucleotide by 
nonspecific activity of Bst Full. However, given that the probe is also labeled 
with a quencher, visualization of a clipped or degraded probe compared to the 
intact probe with traditional staining methods is difficult. Therefore, we looked 
at reactions with only the DNA polymerase and either one of two probes: one 
being the original FRET probe, and the other being that same probe with only 
a 5’ fluorophore.  
In Figure 5.4, when looking at the reactions with the FRET probe (bands 
in blue), reactions with just probe and template show significant clipping of 
fluorophore (lane 1 vs lane 5), even in comparison to the clipping that is 
observed in the presence of the target (lane 6). This observed activity was also 





presence and absence of target, the clipped fluorophore can be visualized, and 
therefore indicates that Bst Full can nonspecifically act on a labeled probe, and 
is thus not the appropriate enzyme for this assay. 
5.3.1.1.2 DNA Polymerase I  
When considering other polymerases with the required exonuclease 
activity, DNA Polymerase I presents an advantage in that it is optimal at the 
same temperature as RNA polymerases. While Bst Full is active at these lower 
operating temperatures, its optimal temperature ranges between 50 – 72 °C. 
Given that its overall activity is at roughly 10-15% as noted by the vendor 
information, we hypothesize that this decreased activity may result in the 
exonuclease being more active than the polymerase function at this suboptimal 
Figure 5.4. Bst Full nonspecifically degrades oligonucletides in the absence of target 
extension. Lanes 1 and 2 show the three sequences involved in the reaction, and serve as 
length reference. Lanes 3 through 6 show the probe and template with and without target for 
both the FRET and 5’ labeled probe. Lanes 7 through 10 are analagous to lanes 3 through 
6, but with the DNA polymerase present. Across the four lanes, we observe incomplete 
degradation of probe, with a significant portion of fluorophore clipped off the probe, shown 





condition. Despite DNA Polymerase I having both 5’  3’ exonuclease activity 
and 3’  5’ exonuclease activity, we hypothesized that the polymerase activity 
would overwhelm both of these exonucleases if the assay temperature and the 
enzyme’s optimal temperature are the same.  
We tested this hypothesis using both a high and low concentration of 
target, alongside an NTC, using the full TCA system. Figure 5.5A shows a 
concentration dependence where the highest target concentration shows a 
higher end-point fluorescence than the lower concentration, suggesting that 
this may be a viable option for the assay. However, when confirming the assay 
products with gel electrophoresis, we observe either smears within a lane or 
shorter bands than expected. Smears are often indicative of degradation 
products, and the short bands of interest (lanes 2 and 3, beneath the template 
and) are potential degradation products of the template. A possible explanation 
Figure 5.5. Impact of DNA Polymerase I for TCA. (A) Real-time curves resulting from probe-
degradataion during TCA of 100 nM and 1 nM target, alongside a no target control (NTC). 
(B) Confirmation of products with gel electrophoresis. Lane 1 are the products from the 
100 nM target reaction, and shows significant degradation products. Lane 2 shows the 
products from the 1 nM reaction, with some degradation products present beneath the 
template. Lastly lane 3 shows the products from the NTC, exhibiting very similar results to 





for this behavior is that once templates have been saturated with extension 
products, the DNA Polymerase I recognizes 3’ ends, and instead of extending, 
the exonuclease becomes active, resulting in the degradation products seen in 
the gel. While there are strategies to avoid degradation of the designed 
template and probe (incorporation of inverted dT bonds, carbon spacers at 
either end of oligonucleotides, etc.), it is difficult to include protection strategies 
for oligonucleotides that are synthesized in vitro by either the DNA or RNA 
polymerases. Additionally, incorporation of these modifications increases the 
cost of the assay and increases the complexity of assay design. 
5.3.1.1.3 phi29 DNA Polymerase 
The last study involving polymerases with exonuclease domains was to 
evaluate a polymerase with an optimal temperature lower than the operating 
temperature of the assay. Unlike the previous two polymerases, this 
polymerase, phi29 DNA polymerase (phi29), does not have a 5’  3’ 
exonuclease activity, but instead has a 3’  5’ exonuclease. As a result, as 
phi29 encounters a DNA strand as it is extending a primer, this DNA would 
simply be pushed off the template instead of degraded. For these experiments, 
a single-labeled probe at the 3’ end and a quenched template were used to 
monitor the real-time fluorescence (as depicted in Figure 5.1A). Initial 
experiments with a high target concentration and an NTC show signal 
generation with significant end-point values for both reactions (Figure 5.6A). 
Gels revealed that (i) there was inefficient extension of target given the intensity 





lane 1). It is likely that the efficiency of phi29 dramatically decreases at 
temperatures above its optimal temperature, which would result in less 
extension of the target as what has been observed with DNA Polymerase I, 
and Bst Full. With this displacement model, any nonspecific transcription can 
lead to the probe being pushed off of the template, separating the fluorophore 
on the probe from the quencher on the template and thus generating a 
fluorescent signal. We hypothesize that there may be unintended synergy 
between the DNA and RNA polymerases that leads to nonspecific T7 RNA 
polymerase activity, and is further elaborated in section 5.3.1.3. Given the 
nonspecific transcription that we observe in lane 1, this is likely to be the cause 
of the fluorescent signal observed in Figure 5.5A. 
 Given the previous experimental results involving a 3’  5’ exonuclease, 
we expect to see the same nonspecific degradation for low target 
concentrations and NTCs. Evidence of this was observed previously with DNA 
Polymerase I, with high target concentrations. In this strand-displacing model, 
Figure 5.6. Impact of phi29 DNA polymerase on TCA. (A) Real-time fluorescence of 
reactions with either 100 nM target or the absence of target (NTC). (B) Denaturing gel shows 
that there is nonspecific transcription present in the NTC, which most likely is what is causing 





it would be difficult to discern in a gel whether there are degradation products 
from the template due to the presence of the quencher, and troubleshooting 
would become cumbersome with the use of hybridized probes or labeling. 
Therefore, we decided to continue with the strand-displacing model of TCA, 
with a DNA polymerase that has no exonuclease activities, also known as 
strand-displacing polymerases. 
5.3.1.1.4 Summary of findings 
Thus far, we have shown that polymerases with exonuclease domains 
are poorly suited for TCA. While each step of the assay generates the expected 
products, these polymerases lead to nonspecific degradation of the 
oligonucleotides.  Consequently, the observed degradation further impacts 
fluorescent measurements, or the stability of the oligonucleotides in the assay. 
The table below further details the activities that have been observed in 
this study. 
Table 5.2. Summary of polymerases with various exonuclease domains' impact on TCA 
Enzyme Exonuclease domains Findings 
Bst Full 5’  3’ 
• Clipping of 5’ fluorophore on probes in 
the absence of target 
• For FRET probes, nonspecific 
degradation of entire probe is apparent 
• For 5’ labeled probes, only clipping of 




5’  3’ 
3’  5’ 
• Degradation of the template is observed 
in the presence and absence of target 





• Poor discrimination between positive 
and negative samples 
 
5.3.1.2 Investigating the impact of strand-displacing DNA 
polymerases 
The next study evaluates polymerases that do not have exonuclease 
domains. Due to the unexpected degradation that was observed across 
polymerases with exonuclease domains, we expect that strand-displacing 
polymerases will offer higher extension efficiencies given the absence of other 
active sites, and minimize downstream troubleshooting given its singular 
function. The two strand-displacing polymerases studied below were selected 
for investigation because of their prevalence in existing isothermal amplification 
schemes. 
5.3.1.2.1 Bst 2.0 
Bst 2.0 is a derivative of Bst Full that has the exonuclease portion 
removed, and has been modified for improved processivity and robustness 
against inhibitors that are common in crude samples (further discussed in 
Chapter 4). However, Bst 2.0 has the same optimal temperature range as Bst 
Full (50 – 72 °C), and therefore its efficiency must be determined for the lower 





Bst 2.0 was evaluated with reactions of the probe and template with 
either only Bst 2.0 present (DNAP only) or both Bst 2.0 and T7 (DNAP and 
RNAP) in either absence or presence of target. Figure 5.7A shows the real-
time amplification curves for these reactions. For reactions with only DNA 
polymerase, there is not a significant change in fluorescent signal in the 
presence or absence of target. This is surprising for reactions containing target, 
as it is expected that extension of the target would lead to the displacement of 
the probe, and generate a fluorescent signal. However, when looking at 
reactions with both polymerases, there is a significant change in signal only in 
NTCs. Products separated by gel electrophoresis show that despite the 
nonspecific transcription we observe in the NTC, the products in all other 
reactions are indicative of a successful amplification reaction (Figure 5.7B). It 
is unclear how or why Bst 2.0 is interacting with the oligonucleotides to produce 
such a low signal in comparison to the NTC, and requires further studies to 
understand the mechanism of the observed behavior. 
Figure 5.7. Impact of Bst 2.0 on TCA. (A) Real-time amplification curves show a high 
fluorescent signal for NTC reactions with both enzymes, in comparison to reactions with 
target or with DNA polymerase enough. (B) Products separated by gel electrophoresis show 
nonspecific transcription in NTC reactions, but reactions with target present show products 





5.3.1.2.2 Klenow exo-  
Klenow exo- (referred to as Klenow in this chapter) is a derivative of 
DNA Polymerase I with both exonuclease domains removed. Klenow therefore 
has the same optimal temperature as TCA’s operating temperature of 37 °C, 
and has been previously used for amplification schemes like RCA (described 
in section 2.3.2.2.3). We assessed these two enzymes for TCA by evaluating 
the real-time amplification curves, and assessing the degree of nonspecific 
transcription occurring in the reaction. 
From previous experiments using Bst 2.0 and phi29, nonspecific 
transcription activity of T7 is present in all NTC reactions, and therefore when 
assessing Klenow as a DNA polymerase candidate, it was expected that NTC 
reactions would still show RNA transcripts. Therefore, preliminary studies with 
Klenow only evaluated target dilutions in TCA reactions and their fluorescent 
signals. The expected signal for these reactions should appear as a sigmoidal 
curve, instead of the relatively flat signals observed with Bst 2.0. The sigmoidal 
curve would indicate that RNA has been robustly generated, and the RNA has 
bound onto the template for extension and probe displacement for exponential 
signal generation.  
 Fluorescent signals from reactions with Klenow have drastically different 
signals, compared to those using Bst 2.0. Signal gains of roughly 0.1 RFU 
(typical of PCR reactions run on this instrument) are observed across all target 





of RNA across all lanes in the gels (Figure 5.8B). Additionally, the sigmoidal 
curves that are characteristic of exponential amplification reactions is now more 
apparent. It is important to note that there is no concentration-dependent 
amplification that is normally observed, and this is most likely due to the 
nonspecific transcription activity of the RNA polymerase. However, this 
behavior can be addressed with investigating other RNA polymerases besides 
T7, and also optimizing buffer conditions to promote and inhibit the activity of 
either polymerase as needed. 
5.3.1.2.3 Summary of findings 
Unlike polymerases with exonuclease domains, strand-displacing 
polymerases are better suited for TCA given their singular function of DNA 
extension. However, it is important to note that across the strand-displacing 
polymerases, we now observe nonspecific transcription, where in the presence 
of a single-stranded promoter, T7 RNA polymerase still initiates transcription, 
Figure 5.8. Investigating the impact of Klenow on TCA. (A) Real-time amplification curves 
of reactions with varying concentrations of target show a sigmoidal amplification curve, 
characteristic of exponential amplification reactions. (B) Products separated by gel 






and thus limits the sensitivity of our assay. The table below summarizes the 
phenomena observed in this study. 
Table 5.3. Summary of observed findings using strand-displacing polymerases for TCA. 
Enzyme Findings 
Bst 2.0 
• Inefficient extension of target 
• No change in real-time signals in the presence of target 
• Sharp change in real-time signals in the absence of target 
Klenow 
• Real-time fluorescence shows sigmoidal amplification 
curves, indicative of exponential amplification 
• High efficiency of target extension 
• Poor discrimination between positive and negative 
samples 
 
5.3.1.3 Investigating various RNA polymerases to limit nonspecific 
transcription 
Thus far, TCA is shown to suffer greatly from nonspecific transcription. 
While there is consensus in the nucleic acids field that transcription only occurs 
when the promoter is double-stranded, the work presented here has shown that 
the presence of a single-stranded promoter, specifically the anti-sense 
sequence, is still recognized by the T7. When reviewing possible causes for 
this behavior, it is important to note that transcription in the presence of a 
single-stranded promoter is often not considered in assessing the specificity of 
the enzyme. Because RNA polymerases are often used for in vitro cloning, 
groups have leveraged the sequence-specific nature to ensure strong 
transcription, with little regard to whether transcription occurs in the presence 





T7 does not require a double-stranded promoter for transcription,232 however 
most groups that have researched the impact of duplexed promoter regions 
have used purified RNA polymerases isolated from bacteria.233,234 While the 
observed behavior may stem from domains present in T7 RNA polymerases in 
vivo, it is unclear if directed evolution methods normally employed by 
commercial vendors have addressed these phenomena. A more recent paper 
has shown that this observed behavior negatively impacts amplification 
schemes, like RCA (described in section 2.3.2.2.3) for RNA detection described 
by Li, et al.,235 where nonspecific activity of the T7 leads to very high limits of 
detection and negatively impacts binding and melting of DNA nanostructures 
leveraged for biosensing.236 This suggests that activity with a single-stranded 
promoter is more common with commercial RNA polymerases than those 
purified from in vitro cloning. 
Another aspect to note is that traditional transcription reactions are 
normally done only in the presence of an RNA polymerase, whereas our 
system involves both DNA and RNA polymerases. While Li, et al., has shown 
that T7 alone leads to false positives, preliminary tests with our sequences 
show that NTC reactions with T7 alone does not lead to any transcription (data 
not shown). Nonspecific transcription only occurs when both T7 and a DNA 
polymerase are present, supporting the hypothesis that the enzymes may be 
working in tandem during the reaction, inadvertently enabling transcription. 
Recently, Emery, et al., published a paper where both Bsu DNA polymerase, 





nonspecific transcription observed in TCA,237 and claimed this behavior can 
generally occur with a wide variety of DNA polymerases. However, strategies 
to mitigate this activity are not discussed given the challenges in investigating 
the different mechanisms at play. 
While it is unlikely that nonspecific transcription can be totally eliminated 
with the use of other common bacteriophage RNA polymerases, such as SP6 
and T3, we hypothesize that SP6 RNA Polymerase (SP6) may be a more 
suitable enzyme for TCA. A previous report investigated the impact of transcript 
length and sequence on transcription yield using SP6, as previous groups have 
shown that T7 transcription is significantly impacted by these factors.229,230 
Stump and Hall have shown specifically for short RNA transcripts that SP6 RNA 
polymerase is very efficient,238 producing a high yield of products. In addition, 
studies were conducted to compare the yields of full duplexed promoters and 
partially duplexed promoters using SP6 and T7 RNA polymerases. While the 
partial duplex showed 5% relative yield in comparison to the full duplex with 
SP6, the partial duplex with T7 RNA polymerase produced roughly a third of 
yield to the full duplex control. This specificity of SP6 is promising for TCA 
applications, where the observed minimal SP6 transcription with a partial 
duplex promoter may lead to further diminished activity with a single-stranded 
promoter. Additionally, because the transcripts produced in TCA are roughly 






Preliminary studies were conducted using our TCA system, redesigned 
with templates containing the anti-sense promoter of either SP6 or T7, where 
transcription yields were qualitatively assessed. These conditions involved 
assessing transcription with a single-stranded promoter, a partial duplex 
(where only the promoter region is double-stranded, and the transcribed region 
is single-stranded), and a full duplex (both the promoter and transcription 
regions are double-stranded). 
 
 In Figure 5.9, lanes 1 – 3 assess the activity of SP6 against a single- 
stranded promoter. In instances of only SP6 or both a DNA polymerase and 
Figure 5.9. Assessing the activity of SP6 and T7 RNA polymerases with single-stranded, 
partial duplex, or full duplex promoters. Lanes 1-3 and 7-9 evaluate nonspecific transcription 
of the RNA polymerase alone or in tandem with a DNA polymerase with a single-stranded 
promoter. Lanes 4-6 and 10-12 evaluate specific transcription with partial (lanes 5 and 11) 
and full duplex (lanes 6 and 12) promoters. SP6 shows more specific and robust activity in 
comparison to T7. All probe-template and promoter-template duplexes were prehybridized 






SP6 present, little to no transcription can be observed between the probe and 
template bands. Lanes 4 – 6 assess the activity of SP6 with either a partial 
duplex or a full duplex promoter and transcription region. The partial duplex in 
lane 5 leads to transcription, however the yield is distinctly less than the 
transcription observed with the full duplex in lane 6. This suggest that once 
target extension has occurred in TCA, robust transcription should be apparent 
and enable positive feedback into the reaction. Lanes 7-12 assess the same 
conditions with T7. Interestingly, for reactions with only probe and template 
(single-stranded promoter only), transcription is observed only when both DNA 
and RNA polymerases are present (lane 9), similar to what has been observed 
previously. The amount of transcription is comparable to the observed band 
with a partial duplex (lane 11). Because the template used for these T7 
experiments is the symmetric template for TCA, a brighter RNA band is not 
observed in lane 12 for the full duplex, however multiple higher molecular 
weight products are observed instead. This indicates that the transcripts have 
fed back into the system and have been extended by the DNA polymerase. 
From these results, SP6 appears to be a more specific and robust enzyme, 
when compared to T7, and in turn, may be better suited for TCA. 
5.3.1.3.1 Summary of findings 
From these preliminary studies, we have found that T7 is a very robust 
RNA polymerase, capable of transcription of both a double- and single-
stranded purposes. Because TCA is dependent on transcription only in the 





polymerase candidate that may offer more specificity than T7. SP6 was shown 
to be more robust in the presence of the double-stranded promoter when 
compared to T7, and shows no observed transcription with a single-stranded 
promoter. The table below further summarizes the other results of these 
preliminary studies. 
Table 5.4. Summary of findings investigating RNA polymerases for TCA. 
Enzyme Findings 
SP6 
Probe and template (single-stranded promoter) 
• No observed transcription alone or in the 
presence of DNA polymerase 
Promoter and template 
• In the presence of SP6 alone (partial duplex), 
observe low transcription activity 
• In the presence of SP6 and DNA polymerase 
(full duplex), observe high transcription activity 
T7 
Probe and template (single-stranded promoter) 
• Observe minimal transcription  alone or in the 
presence of DNA polymerase 
Promoter and template 
• In the presence of SP6 alone (partial duplex), 
observe stronger transcription activity 
• In the presence of SP6 and DNA polymerase 
(full duplex), observe higher molecular weight 
products that would arise from extensions of 
RNA products, suggesting there is high 
transcription activity 
 
5.3.2 Assay performance with Klenow and SP6 
 Now that both Klenow and SP6 polymerases have been selected as the 
optimal enzymes for TCA, experiments were performed to evaluate the limit of 
detection and to assess whether further optimizations were required to achieve 
lower sensitivities. Initial experiments show that across all target 





concentrations of 100 nM, 10 nM, and 1 nM (Figure 5.10). However the NTC 
amplifies similarly to the 1 nM target concentrations, and all lower target 
concentrations, indicating that the low amount of nonspecific transcription is 
possibly doing one of two things.  
 
The first possibility is that the generated transcript in the NTC simply 
displaces the probe, but remains hybridized to the template. In such an 
instance, the amplification curves that are observed would be linear, with trace 
amounts of transcripts visible in the gels. The second possibility is that the 
transcripts produced nonspecifically continue to be displaced with constant 
activity of RNA polymerase, and would in turn lead to exponential amplification. 
Here, a bright band of RNA transcripts would be observed, comparable to that 
belonging to a reaction with target, due to the stronger activity of RNA 
polymerase in the presence of a full duplex promoter and transcription region. 
These two possibilities are further explored in the next section. 
Figure 5.10. Amplification curves for various concentrations of target with Klenow and SP6 
polymerases. Given the early amplification in the NTC, the limit of detection with the current 





5.3.3 Alternative template designs 
As mentioned previously, there are two possibilities that could be 
contributing to the signal observed in NTC reactions. One instance would lead 
to linear amplification, and the second would lead to exponential amplification. 
To determine which of these phenomena is occurring, a second linear template 
was designed such that the sequence locations of the promoter and the user-
designed sequence for probe hybridization were switched. With this template, 
in the presence of the target, the probe would get displaced immediately, 
followed by the formation of the promoter and transcription duplex. 
Transcription would then lead to RNA products feeding back into the system. 
However, if nonspecific transcription were to occur in NTC reactions, the probe 
should not be displaced unless the transcripts bind to the 3’ end of the template 
and begin extension. 
  Figure 5.11A shows the products separated with gel electrophoresis 
with the second template, assessing the specific versus nonspecific activity in 
the presence and absence of target, respectively. As noted earlier, should 
exponential amplification occur, the band intensity of RNA should be equal in 
comparable between the two reactions. Lanes 1 and 2 do show comparable 
intensity of RNA transcripts. As a result, alternative strategies were investigated 






 Throughout this work, a linear template has been used to simplify the 
design in a cost-effective manner. However, given the persistence of T7 and 
SP6 activity for the various templates and enzymes tested, a concern is that 
the linear nature of the template facilitates quicker binding of both the DNA and 
RNA polymerases, especially in instances of low target concentrations or 
absence of target entirely. We thus hypothesized that if the promoter region is 
obscured with the introduction of secondary structures within the template, this 
would decrease the accessibility of the promoter region to the RNA polymerase 
and in turn decrease the nonspecific RNA polymerase activity. To test this 
hypothesis, the template was redesigned such that while it was still symmetric 
to allow transcription to create target analogs, the 5’ half of the template would 
be folded into a hairpin configuration, where the loop portion would contain the 
Figure 5.11. Investigation of alternative templates to minimize nonspecific transcription. (A) 
By switching the promoter and probe hybridization regions, the generated transcripts are 
indicative of their participation into the assay’s positive feedback. (B) Redesign of template 
involved obscuring the promoter with the loop of a hairpin structure, to obstruct the RNA 
polymerase’s ability of reading and binding onto the promoter sequence. While there is a 
subtle decrease in transcription observed in NTC reactions (lane 2), it is still comparable to 
levels observed with target present in the reaction (lane 1). All reactions for these 
experiments contained 3 U of Klenow and 5 U of SP6, to further minimize the occurrence of 





promoter sequence (Figure 5.11B). Reactions with the addition or absence of 
target showed that a lesser amount of transcription occurred in the NTC (lane 
3) as compared to the target-containing reaction (lane 2); however, the 
transcripts are of sufficient quantity to negatively impact the limit of detection 
for the assay. 
 The results from these studies show that templates that are either linear 
or contain some secondary structure to obscure the single-stranded promoter, 
RNA polymerase is still able to recognize the promoter sequence and initiate 
transcription.  When assessing what is mechanistically occurring with the 
hairpin template, it is unclear whether the RNA polymerase reads in the 3’  5’ 
direction and displaces the hairpin to initiate transcription, or if the loop of the 
hairpin does not change the interactions between the RNA polymerase and the 
promoter region of the template. Further studies are required to better evaluate 
the feasibility of the template for alternative iterations of TCA. 
5.3.4 Optimizing buffer conditions 
Thus far, the optimizations we have considered towards limiting that 
amount of nonspecific activity involve enzyme and template design 
considerations. However, a key component towards any successful 
amplification reaction are the buffer components. Often, the buffer components 
of an assay largely promote activity of an enzyme, and for systems that 
leverage multiple enzymes, these buffer conditions can bias the activity of one 





RNA polymerases are highly sensitive to monovalent cations, and thus all 
transcription reactions normally use 10 mM of monovalent cations. However, 
NASBA, a popular isothermal method developed for the direct detection of 
mRNA and large RNA targets, leverages T7 to produce transcripts in the 
presence of 70 mM monovalent cations. Therefore, the last strategy we 
employed was investigating if monovalent cations can be used to selectively 
promote the activity of SP6, while concurrently inhibiting the nonspecific activity 
that has been observed throughout this work. 
Traditionally, amplification reactions have used monovalent cations 
such as sodium and potassium in reaction buffers. Therefore, various amounts 
of either sodium chloride or potassium chloride were used to investigate the 
impact of these cations on both the specific and nonspecific activities of SP6 
with the presence and absence of target, respectively. Since NASBA generally 
uses a concentration of 70 mM monovalent cations, this was chosen as the 
highest assayed concentration.  
For reactions with NaCl addition (Figure 5.12A), as the NaCl 
concentration increases there is an observed decrease in the amount of 
transcription occurring in the NTCs, indicative of less nonspecific SP6 activity. 
However, the specific activity of the enzyme is compromised given the reduced 
band intensities of reactions with target. Reactions with KCl addition (Figure 
5.12B) show a similar trend to NaCl, however reactions containing 40 mM KCl 
and higher reveal a distinct difference in transcription in the presence and 





band intensity as compared to reactions with target, suggesting that higher KCl 
concentrations can be leveraged to favor specific activity of the RNA 
polymerase. However, it is important to note that the reactions with target, 
namely lanes 7 and 9, have a decreased band intensity compared to the 
reactions with no supplemented KCl (lane 1). While the KCl allows for 
transcription selectively with a double-stranded promoter, the activity of the 
polymerase is overall reduced, and potentially increased assay times may be 
required.  
While RNA polymerases maintain strong activity at 37 °C, their optimal 
temperature is normally at 40 – 42 °C.239 The experiments that have been 
presented throughout this work have been incubated at 37 °C to ensure activity 
of both enzymes. Since Klenow is robust against the higher concentrations of 
Figure 5.12. Impact of monovalent salts on specific and nonspecific RNA polymerase 
activity. (A) Varying amounts of sodium chloride were added to reactions with and without 
target. Overall there is diminished SP6 activity given the decreased RNA band intensities 
with increasing sodium content. Additionally there is no distinct difference in the transcription 
yields when comparing reactions with and without target for each concentration. These 
experiments used the template tested in Figure 5.11A, where the template is unlabeled and 
thus stains strongly in the gel. (B) Varying amounts of potassium chloride were added to 
reactions with and without target. While transcription yields overall decreased with increasing 
potassium content, with 40 mM and 60 mM there is more intense RNA band in reactions with 
target compared to those without. This suggest that nonspecific SP6 activity may be inhibited 
without totally inhibiting its specific activity. The original quenched template was used in 
these experiments, and consequently the template does not appear strongly in this gel. (C) 
To recover the specific SP6 activity, reactions were incubated at 42 °C and 37 °C to 
determine if improved activity could be visualized with real-time fluorescence. While 
reactions with and without target cannot be differentiated at 37 °C, a concentration-
dependent fluorescence can be observed when incubated at 42 °C. All reactions here 





monovalent cations presented, it is critical to also ensure that the specific 
activity of SP6 is also maintained for robust exponential feedback. To evaluate 
whether an increased assay temperature would improve fluorescent signals, 
the labeled probe and quenched template were incubated with and without 
target in parallel reaction at either 37 °C or 42 °C using the BioRad 
thermocyler’s gradient protocol (Figure 5.12C). Reactions incubated at 37 °C 
saw minimal signal differences between 10 nM and 1 nM target in the reaction 
compared to the NTC, however reactions incubated at 42 °C saw more drastic 
differences that would increase the dynamic range of the assay and potentially 
lower the previously observed sensitivity and limit of detection. 
While the inclusion of monovalent salts can inhibit the overall efficiency 
of the RNA polymerases, we have shown that raising the operating temperature 
of the assay helps recover some of the activity. Future work to further 
discriminate the dynamic range and achieve higher quality sigmoidal 
amplification curves will involve the addition of BSA and DMSO, two known 
chemical agents that promote polymerase activities. These studies will first 
involve optimizing these agents to better characterize their individual and 
collective impact on target extension and transcription yield. With these 
additive, we hope that rapid and sensitive quantification can be achieved. 
5.4 Conclusion 
miRNA detection platforms currently are time-consuming due to the 
time-consuming two-step process of RT-PCR, and prevent rapid quantification 





enables isothermal exponential amplification that can be further expanded to 
include multiplex detection. However, before this assay can be implemented 
for miRNA detection, there are several questions that need to be addressed to 
better inform design constraints of the assay. 
We first investigated the impact of DNA polymerases for this assay. In 
these studies, we found that DNA polymerases with exonucleases domain 
negatively impact the assay, where nonspecific degradation of sequences 
either led to false positives, or the instability of oligonucleotides. 
Strand-displacing polymerases addressed this issues as they do not have 
exonuclease domains, however depending on the enzyme, fluorescent signals 
were not generated as expected despite generating the products that indicate 
successful amplification. However, with these experiments, we found that 
Klenow was the strongest candidate for the DNA polymerase in this system.  
Second, we looked to optimize the RNA polymerase activity by 
assessing the transcription yield of SP6 and T7 polymerase. Overall, we have 
observed nonspecific transcription with a single-stranded promoter with the use 
of T7, and thus we investigated the performance of SP6 with a single-stranded 
promoter, and varying degrees of duplex promoters, in comparison of T7. We 
found that there was no observed transcription in the presence of a 
single-stranded promoter with both SP6 and a DNA polymerase, however with 
T7 and a DNA polymerase, we observed low transcription yield. More 
importantly, we observed robust transcription with SP6 with a double-stranded 





specificity of SP6, we found that SP6 was the strongest candidate for the RNA 
polymerase in this system. 
We sought to eliminate the reduced nonspecific transcription activity 
with various template designs, and introducing monovalent cations into our 
system. Unfortunately, transcription was observed with the different linear 
designs and the hairpin template format, however further studies need to be 
conducted to better understand how SP6 interacts with the template to initiate 
transcription with a single-stranded promoter. Drawing on NASBA buffer 
conditions, we investigated the inhibitory impact of monovalent cations to bias 
the specific activity of SP6 and eliminate the nonspecific activity. While NaCl 
did not show promise towards biasing this behavior, KCl showed no 
transcription in the absence of target and a moderate amount of transcription 
in the presence of target, suggesting that KCl along with other chemical agents 
may improve the dynamic range of TCA. 
Future work of TCA will involve optimization of KCl concentrations, 
investigating whether polymerase promoters such as DMSO and BSA will need 
to be integrated into the assay to recover any diminished activity at higher KCl 
concentrations, and evaluation of the dynamic range, sensitivity and limit of 
detection of TCA. Once an initial formulation for TCA mastermix has been 
devised, the amplification of other miRNA targets with varying degrees of 
secondary structures will need to be validated. We expect that with these 
miRNA targets, such as mi-R21 and mi-R16, we will observe a decrease in 





onto the template. In such cases, chemical agents that weaken the stability of 
secondary structures (i.e. betaine) will be investigated, and we will assess if 
these chemical agents can be applied universally to all miRNA targets or only 
those with secondary structures. 
The culmination of this work will ultimately lead to a platform suitable for 
both commercial and research applications that aims to quantify multiple 
miRNA targets. The work presented here further informs the diagnostic and 
biochemistry communities about the interactions of nucleic acids alongside 







Chapter 6. Conclusion 
6.1 Overview  
This work details the development of technologies and assays to simplify 
the traditional approaches to sample preparation and nucleic acid amplification 
for near-patient settings. First, this work aims to invent a novel sample 
preparation method that moves away from the cumbersome reagent exchange 
approach and accomplishes the three time consuming tasks of cell lysis, DNA 
extraction, and DNA purification in a single-step. Second, we address the 
limitations of PCR (complex instrumentation due to thermocycling) by either 
leveraging or designing novel isothermal amplification schemes that enable 
multiplex detection in a single reaction. Simplifying these modules to enable a 
single-step or single-tube format not only minimizes the technical burden 
associated with these protocols, but enables a streamlined method towards 
cheap, rapid, and comprehensive diagnostic tests. 
6.2 Chapter 3: Simplifying nucleic acid amplification from whole blood 
blood with direct PCR on chitosan microparticles 
While there is consensus that the laborious nature of sample preparation 
is a bottleneck towards an integrated device for NAATs, there has been little 
direction for strategies to approach this challenge. While previous solutions 
have either miniaturized these steps, or have leveraged capture probes 
conjugated to the microparticles to enable DNA isolation with standard cell lysis 
techniques, these methods are often difficult to integrate within a device for 





based platform that simultaneously accomplishes cell lysis, DNA extraction, 
and DNA purification from complex matrices. Because bound genomes are 
difficult to elute off the chitosan layer, we have leveraged this to enable direct 
amplification on the solid phase. 
6.2.1 Scientific contributions 
While the application of chitosan-coated microparticles addresses the 
challenges of sample-preparation, the underlying aspects of the platform 
generally advance both research and commercial endeavors. 
• A novel DNA extraction method that leverages classic 
bead-beating techniques that isolates DNA from cells within 10 
minutes amenable to a variety of cell suspensions (buffer, cell 
media, and whole blood). 
• A solid phase extraction technique to enable stable, direct 
amplification on the solid phase. These microparticles provide a 
robust amplification platform for protocols that require high 
temperatures of 95 °C. 
• An isolation method for a variety of targets that range from small 
DNA plasmids to large genomes. 
• A platform that enables multi-stage PCR reactions, where 
products from the first reaction can serve as templates for a 





• A streamlined method where sample preparation steps are 
achieved in 2 manual steps within 10 minutes, where traditional 
methods require roughly 5 manual steps within 30 minutes. 
o The two manual steps involve first adding the cell 
suspension to the chitosan-coated microparticles and 
second, aspirating out the lysate and adding the 
amplification mastermix. 
6.2.2 Limitations and future work 
The work presented in this chapter only investigated the extraction of 
genomic DNA and plasmids that would mimic viral genomes. However it is 
unclear how efficient this platform would be for smaller nucleic acid targets, 
such as mRNAs and miRNAs for expression profiles. Our hypothesis assumes 
that a portion of genomic DNA is embedded within the chitosan matrix, and 
thus limits the accessibility of the polymerase to replicate these regions. While 
the embedded portion of DNA only leads to a 3 – 5 Ct delay when compared 
to a typical solution-based PCR reaction, it is unclear whether this observed Ct 
delay would translate to smaller nucleic acids. In lieu of PCR, NASBA and 
EXPAR would be better amplification systems to assess this as they enable 
direct detection of these sensitive targets. 
I have shown that chitosan-coated microparticles can reduce the 
hands-on steps as well as the time needed to isolate DNA from a complex 





towards sample preparation, it would be interesting to assess the efficiency of 
direct amplification with popular isothermal amplification schemes. 
Demonstration of efficient amplification with methods such as LAMP or RCA 
would drive this platform’s potential towards a device that is significantly less 
resource-intensive compared to PCR-based POC NAATs, specifically for 
resource-limited settings.  
Considering future applications of this platform, chitosan-coated 
microparticles can be integrated within a NAAT by using its magnetic core. 
Actuating the magnetic core of the particle would enable simple transport into 
different NAAT modules, and eliminate the need for user intervention for 
sample transfer. Previously, groups have actuated magnetic particles with an 
external magnet to demonstrate a simple system for reagent handling.240,241 A 
similar approach could be applied to enable sample transfer of the 
chitosan-coated microparticles from sample preparation reagents to an 
amplification reaction. The more challenging aspect of the platform would be 
demonstrating efficient lysis using a bead-beating approach. While using a 
vortexer provides a simple method of lysis on the bench-top, miniaturizing this 
effect is not straightforward, and is often why chemical and thermal agents are 
integrated into POC devices instead. Mixing has been demonstrated within 
microdevices with magnetic particles, but often these applications are looking 
to enhance binding events without cell damage.242–244 It is unclear if these 
systems could be further developed to enable cell lysis. However if this 





the development of an automated system would offer a novel approach towards 
integrated sample preparation and DNA amplification platforms.  
6.3 Chapter 4: Demonstration of a quantitative triplex LAMP assay with 
an improved probe-based readout for the detection of MRSA 
As novel assays are leveraging isothermal amplification schemes 
towards the development of POC NAATs, LAMP is the method at the forefront 
of these endeavors. Its increased specificity and speed in comparison to PCR 
offer attractive features for these tests. However, as the iterations of LAMP 
have improved the robustness and processivity of these enzymes for 
amplification, there is little direction to inform assay design. Chapter 4 details 
the development of a triplex assay towards the identification of MRSA 
genomes, and outlines the factors to consider when designing a multiplex 
assay for rapid detection. This chapter also re-evaluates a probe-based 
detection method for assaying multiple genes within a single genome.  
6.3.1 Scientific contributions 
The work presented in this chapter aimed to inform diagnostic 
developers of factors to consider when designing LAMP assays. The 
information presented was used towards the identification of MRSA by testing 
for the femB, mecA, and spa genes. 
• A single-tube triplex platform that specifically detects the 





• A clear demonstration of TTP comparison with various 
strand-displacing polymerases that have been developed 
specifically for LAMP applications. 
• Insight regarding primer number (four versus six) when using the 
latest iteration of Bst on TTPs, and the resulting sensitivities and 
limits of detection that can be achieved. 
• Evaluation of how DARQ LAMP impacts assays that require low 
magnesium content for two commonly-used strand-displacing 
polymerases.  
6.3.2 Limitations and future work 
Throughout chapter four, we observed inhibition when the QPD was in 
excess, or when the number of primer sets and QPDs increased in the system. 
A significant limitation of this method remains that the exact mechanism of the 
observed inhibition when using FRET probes with LAMP is unclear, especially 
when evaluating each iteration of a strand-displacing enzymes used in this 
work. Without this knowledge, devising strategies to overcome inhibition will be 
challenging. However, traditional means of alleviating delays in amplification 
with chemical agents can be investigated. Specifically, using chemical agents 
to either enhance binding of the probe-quencher duplex (TMAC, ammonium 
sulfate), or enhance the activity of polymerase (DMSO, BSA) can be assessed 





We observed the trend of later amplification with increasing primer sets 
in the reaction. It is very likely that the high concentration of primers (roughly 
9.5 µM) may negatively impact the assay. Further optimizations to determine 
whether high oligonucleotide concentrations should be assessed to elucidate 
the impact of these primers towards TTPs. 
6.4 Chapter 5: Transcription Cycling Amplification: a novel isothermal 
amplification scheme for the direct detection of microRNA 
Robust solutions towards the direct detection of miRNA are lacking 
given the instability of RNA targets. To this end, TCA aims to address this need 
with the use of both DNA and RNA polymerases to create a system with 
positive feedback and achieve exponential signal generation. In this chapter, 
several design considerations were outlined when devising a multi-enzyme 
system, namely the choice of enzymes, template designs, and buffer 
components. 
6.4.1 Scientific contributions 
Chapter 5 details the development and evaluations of design constraints 
towards the development of a novel amplification reactions. While this platform 
was used towards the detection of a single biomarker, the design of a probe 
that participates with the template to achieve FRET can be leveraged for 
multiplex detection. The following observations can inform future development 





• Insight towards the interactions between DNA polymerase and 
RNA polymerase towards nonspecific activity. 
• Strategies to minimize nonspecific activity of both polymerases. 
• Insight regarding using a combination of inhibitors and promoters 
of polymerase activity to selectively reduce nonspecific 
transcription, without compromising specific activity. 
• A novel amplification scheme that can enables sensitive and 
multiplex detection. 
6.4.2 Limitations and future work 
The observed transcription behavior with the single-stranded anti-sense 
promoter has not been previously discussed with RNA polymerases that were 
isolated from bacteria. To better understand this behavior, a study between 
commercial and isolated polymerases can be conducted to ascertain whether 
the directed evolution of the enzyme leads to this behavior, or whether 
addressing nonspecific transcription will remain to be a challenge regardless of 
the enzyme source. 
The work presented in this chapter used the miRNA target let7a, which 
has minimal secondary structures. Most miRNA targets present in a variety of 
secondary structures to promote their stability. Binding of these types of miRNA 
to templates should be evaluated across varying secondary structures. Toe-





and chemical agents like betaine can be used to promote the instability of the 
miRNA; however this may impact the probe and template as well.  
6.5 Afterword 
I have described several technologies and techniques to address the 
challenges of integration of sample preparation and DNA amplification for POC 
NAATS. The contributions outlined here aim to inform considerations towards 
shifting the molecular diagnostic field’s approach from these traditional but 
cumbersome methods. These advances contribute to the goal of developing a 
diagnostic for nucleic acid targets that are low-cost, rapid, and comparable in 
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